https://curecurrent.com/trials/egf-ointment-for-erlotinib-skin-lesion-53001https://curecurrent.com/trials/a-randomized-controlled-trial-comparing-safety-and-efficacy-of-carboplatin-and-paclitaxel-plus-or-minus-sorafenib-bay-43-53002https://curecurrent.com/trials/multicenter-randomized-controlled-trial-adjuvant-chemotherapy-vs-observation-in-pstage-ib-lung-adenocarcinoma-53003https://curecurrent.com/trials/vorinostat-carboplatin-and-paclitaxel-in-treating-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-53004https://curecurrent.com/trials/celecoxib-treatment-for-lung-cancer-53005https://curecurrent.com/trials/a-study-to-evaluate-pazopanib-in-comparison-to-pemetrexed-in-maintenance-setting-in-non-progressing-subjects-with-metast-53006https://curecurrent.com/trials/bevacizumab-plus-chemotherapy-for-advanced-non-small-cell-lung-cancer-patients-as-1st-line-treatment-53007https://curecurrent.com/trials/thromboprophylaxis-for-patients-undergoing-surgical-resection-for-colon-cancer-53008https://curecurrent.com/trials/study-of-chemotherapy-plus-icotinib-to-treat-egfr-mutation-positive-non-small-cell-lung-cancer-53009https://curecurrent.com/trials/an-exploratory-study-of-ocz103-os-in-combination-with-standard-of-care-in-stage-iv-non-small-cell-lung-cancer-nsclc-pati-53010https://curecurrent.com/trials/single-scope-staging-of-lung-cancer-with-endosonography-53011https://curecurrent.com/trials/the-efficacy-and-safety-of-nab-paclitaxel-in-pretreated-patients-with-extensive-disease-of-small-cell-lung-cancer-53012https://curecurrent.com/trials/celecoxib-and-erlotinib-in-treating-former-smokers-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53013https://curecurrent.com/trials/role-of-rapid-on-site-evaluation-for-mutational-analysis-of-ebus-tbna-specimens-53014https://curecurrent.com/trials/a-study-of-home-administration-of-pemetrexed-as-maintenance-treatment-for-advanced-nonsquamous-non-small-cell-lung-cance-53015https://curecurrent.com/trials/a-phase-ii-study-of-capecitabine-and-docetaxel-in-previously-untreated-advanced-non-small-cell-lung-cancer-patients-53016https://curecurrent.com/trials/pilot-study-of-18f-faza-in-assessing-early-functional-response-in-patients-with-inoperable-non-small-cell-lung-cancer-un-53017https://curecurrent.com/trials/safety-and-efficacy-study-of-reolysin-in-the-treatment-of-bone-and-soft-tissue-sarcomas-metastatic-to-the-lung-53018https://curecurrent.com/trials/pilot-project-of-adaptive-thoracic-radiotherapy-for-small-cell-lung-cancer-53019https://curecurrent.com/trials/azd2171-in-treating-patients-with-recurrent-small-cell-lung-cancer-53020https://curecurrent.com/trials/a-study-comparing-chemotherapy-dosing-based-on-either-standard-body-surface-area-or-lean-body-mass-in-patients-with-adva-53021https://curecurrent.com/trials/pre-operative-assessment-of-chest-wall-invasion-in-nsclc-using-pre-operative-surgeon-performed-ultrasound-53022https://curecurrent.com/trials/study-of-egfr-tki-to-asymptomatic-brain-metastases-of-nsclc-53023https://curecurrent.com/trials/carboplatin-and-paclitaxel-combined-with-cetuximab-and-or-imc-a12-in-patients-with-advanced-non-small-cell-lung-cancer-53024https://curecurrent.com/trials/an-international-study-on-the-use-of-pet-ct-in-radiotherapy-planning-in-low-and-middle-income-countries-53025https://curecurrent.com/trials/individualized-chemotherapy-based-on-brca1-and-rrm1-mrna-for-advanced-non-small-cell-lung-cancer-nsclc-53026https://curecurrent.com/trials/erlotinib-versus-gemcitabine-carboplatin-in-chemo-naive-stage-iiib-iv-non-small-cell-lung-cancer-patients-with-epidermal-53027https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-carboplatin-based-chemotherapy-in-patients-with-advanced-or-recurrent-53028https://curecurrent.com/trials/a-feasibility-study-of-oral-adjuvant-chemotherapy-with-s-1-53029https://curecurrent.com/trials/effects-of-palliative-care-on-quality-of-life-and-symptom-control-in-patients-with-stage-i-stage-ii-or-stage-iiia-non-sm-53030https://curecurrent.com/trials/a-one-year-study-to-evaluate-the-effects-and-safety-of-cp-690-550-in-patients-with-moderate-to-severe-chronic-plaque-pso-53031https://curecurrent.com/trials/gw786034-in-patients-with-non-small-cell-lung-cancer-3rd-line-53032https://curecurrent.com/trials/a-one-year-study-to-evaluate-the-efficacy-and-safety-of-cp-690-550-for-patients-with-moderate-to-severe-chronic-plaque-p-53033https://curecurrent.com/trials/a-study-of-the-hsp90-inhibitor-sta-9090-in-subjects-with-stage-iiib-or-iv-non-small-cell-lung-cancer-nsclc-53034https://curecurrent.com/trials/improving-clinician-communication-skills-iccs-53035https://curecurrent.com/trials/erlotinib-versus-pemetrexed-as-second-line-therapy-in-treating-patients-with-advanced-lung-adenocarcinoma-53036https://curecurrent.com/trials/maximum-tolerated-dose-safety-and-efficacy-of-docetaxel-cisplatin-sti571-53037https://curecurrent.com/trials/study-of-small-doses-of-etoposide-as-maintenance-treatment-in-small-cell-lung-cancer-sclc-53038https://curecurrent.com/trials/telomere-biology-in-early-adenocarcinoma-of-the-lung-53039https://curecurrent.com/trials/a-clinical-study-with-mt-102-in-subjects-with-cancer-cachexia-53040https://curecurrent.com/trials/risk-adapted-stereotactic-body-radiotherapy-for-early-non-small-cell-lung-cancer-using-the-vero-stereotactic-body-radio-53041https://curecurrent.com/trials/clinical-impact-of-eus-in-staging-nsclc-53042https://curecurrent.com/trials/etoposide-carboplatin-alone-or-with-endostar-for-extensive-disease-small-cell-lung-cancer-ed-sclc-53043https://curecurrent.com/trials/testing-of-computer-aided-detection-software-for-riverain-medical-group-53044https://curecurrent.com/trials/study-using-a-genomic-predictor-of-platinum-resistance-to-guide-therapy-in-stage-iiib-iv-non-small-cell-lung-cancer-53045https://curecurrent.com/trials/pmrr-no-pulmonary-metabolic-radiation-response-versus-exhaled-nitric-oxide-53046https://curecurrent.com/trials/abr-217620-in-patients-with-advanced-non-small-cell-lung-cancer-renal-clear-cell-carcinoma-or-pancreatic-cancer-53047https://curecurrent.com/trials/abr-217620-in-combination-with-docetaxel-in-patients-with-advanced-non-small-cell-lung-cancer-53048https://curecurrent.com/trials/clinical-observation-of-s1-capsule-for-stage-a-non-small-cell-lung-cancer-after-complete-resection-53049https://curecurrent.com/trials/blood-samples-from-patients-with-non-small-cell-lung-cancer-and-from-healthy-volunteers-53050https://curecurrent.com/trials/cognitive-behavioral-therapy-in-treating-anxiety-in-patients-with-stage-iv-non-small-cell-lung-cancer-and-their-caregive-53051https://curecurrent.com/trials/bortezomib-in-treating-patients-with-stage-iiib-or-stage-iv-lung-cancer-53052https://curecurrent.com/trials/a-proof-of-concept-study-to-assess-the-ability-of-18f-ah-111585-pet-imaging-to-detect-tumours-and-angiogenesis-53053https://curecurrent.com/trials/study-on-thrombosis-therapy-in-german-cancer-patients-53054https://curecurrent.com/trials/icotinib-with-concurrent-radiotherapy-versus-chemotherapy-with-concurrent-radiotherapy-in-non-small-cell-lung-cancer-53055https://curecurrent.com/trials/azd6244-versus-pemetrexed-alimta-in-patients-with-non-small-cell-lung-cancer-who-have-failed-one-or-two-prior-chemothera-53056https://curecurrent.com/trials/dose-escalation-study-of-bi-2536-with-pemetrexed-in-previously-treated-patients-with-non-small-cell-lung-cancer-53057https://curecurrent.com/trials/study-of-abt-510-thrombospondin-analogue-in-patients-with-advanced-head-and-neck-cancer-53058https://curecurrent.com/trials/nab-paclitaxel-treatment-in-advanced-squamous-cell-carcinoma-of-lung-53059https://curecurrent.com/trials/survival-study-of-docetaxel-and-carboplatin-as-neo-adjuvant-vs-adjuvant-chemotherapy-in-early-stage-nslc-53060https://curecurrent.com/trials/single-dose-escalation-study-of-131i-sibrotuzumab-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-53061https://curecurrent.com/trials/lung-tumour-volume-database-53062https://curecurrent.com/trials/chemoradiotherapy-in-patients-with-localised-lung-cancer-53063https://curecurrent.com/trials/early-detection-of-lung-cancer-via-bi-plane-correlation-chest-imaging-53064https://curecurrent.com/trials/cediranib-maleate-in-treating-patients-with-malignant-mesothelioma-that-cannot-be-removed-by-surgery-53065https://curecurrent.com/trials/phase-ii-clinical-study-of-intermittent-high-dose-of-icotinib-in-combination-with-docetaxel-to-treat-lung-cancer-53066https://curecurrent.com/trials/photodynamic-therapy-in-treating-patients-with-lung-cancer-53067https://curecurrent.com/trials/biodistribution-study-with-186-re-labelled-humanised-monoclonal-antibody-biwa-4-in-patients-with-non-small-cell-lung-can-53068https://curecurrent.com/trials/a-study-of-dasatinib-with-concurrent-chemoradiation-for-stage-iii-non-small-cell-lung-cancer-nsclc-53069https://curecurrent.com/trials/genotyping-of-non-small-cell-lung-cancer-53070https://curecurrent.com/trials/study-of-changes-of-lymphocyte-subsets-in-chemotherapy-course-of-patients-with-non-small-cell-lung-cancer-53071https://curecurrent.com/trials/safety-and-tolerability-of-trametinib-in-combination-with-docetaxel-in-japanese-subjects-with-non-small-cell-lung-cancer-53072https://curecurrent.com/trials/ketamine-in-thoracic-surgery-kits-trial-53073https://curecurrent.com/trials/quit-smoking-program-for-lung-cancer-patients-families-the-family-ties-project-53074https://curecurrent.com/trials/dose-escalation-study-of-bibh-1-in-patients-with-non-small-cell-lung-cancer-scheduled-for-surgical-resection-53075https://curecurrent.com/trials/study-of-the-effect-on-non-small-cell-lung-cancer-of-the-investigational-drug-motexafin-gadolinium-when-used-in-combinat-53076https://curecurrent.com/trials/laboratory-study-using-samples-from-patients-with-non-small-cell-lung-cancer-treated-on-clinical-trial-case-2507-53077https://curecurrent.com/trials/non-invasive-biomarkers-for-early-detection-of-lung-cancers-53078https://curecurrent.com/trials/icotinib-combined-with-whole-brain-radiotherapy-in-treating-multiple-brain-metastases-from-non-small-cell-lung-cancer-53079https://curecurrent.com/trials/bibw2992-afatinib-in-advanced-egfr-fish-nsclc-non-small-cell-lung-cancer-patients-53080https://curecurrent.com/trials/japanese-study-of-ipilimumab-administered-in-combination-with-paclitaxel-carboplatin-in-patients-with-nonsmall-cell-lung-53081https://curecurrent.com/trials/dmr-during-first-line-treatment-of-non-squamous-lung-cancer-time-course-and-prognostic-and-predictive-impact-53082https://curecurrent.com/trials/adjuvant-cisplatin-with-either-genomic-guided-vinorelbine-or-pemetrexed-for-early-stage-non-small-cell-lung-cancer-53083https://curecurrent.com/trials/chemotherapy-combined-with-yangzhengxiaoji-capsule-in-patients-with-advanced-non-small-cell-lung-cancer-53084https://curecurrent.com/trials/dose-escalation-of-bibf-1120-combined-with-pemetrexed-in-advanced-non-small-cell-lung-cancer-53085https://curecurrent.com/trials/a-dose-escalation-study-of-bibf-1120-together-with-paclitaxel-and-carboplatin-in-patients-with-advanced-stage-non-small-53086https://curecurrent.com/trials/sequential-and-maintenance-icotinib-plus-chemotherapy-versus-icotinib-maintenance-after-chemotherapy-in-advanced-nsclc-53087https://curecurrent.com/trials/phase3-study-of-amrubicin-with-cisplatin-versus-etoposide-cisplatin-for-extensive-disease-small-cell-lung-cancer-53088https://curecurrent.com/trials/a-study-of-morab-009-in-subjects-with-pancreatic-cancer-mesothelioma-or-certain-types-of-ovarian-or-lung-cancer-53089https://curecurrent.com/trials/concurrent-chemoradiotherapy-using-intensity-modulated-radiotherapy-imrt-docetaxel-cisplatin-or-carboplatin-followed-by-53090https://curecurrent.com/trials/immunotherapy-with-tg4010-in-patients-with-advanced-non-small-cell-lung-cancer-53091https://curecurrent.com/trials/dasatinib-in-advanced-squamous-cell-lung-cancer-53092https://curecurrent.com/trials/an-open-label-study-of-gsk1120212-compared-with-docetaxel-in-stage-iv-kras-mutant-non-small-cell-lung-cancer-53093https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-docetaxel-and-cisplatin-in-patients-with-metastatic-or-locally-advanc-53094https://curecurrent.com/trials/immunotherapy-with-racotumomab-versus-support-treatment-in-advanced-non-small-cell-lung-cancer-patients-53095https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-monotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-53096https://curecurrent.com/trials/phase-iii-of-rrm1-ercc1-directed-customized-chemotherapy-for-the-treatment-of-patients-with-nsclc-53097https://curecurrent.com/trials/determination-of-safety-efficacy-and-pharmacokinetics-of-regorafenib-combined-with-pemetrexed-and-cisplatin-in-patients-53098https://curecurrent.com/trials/dose-dense-induction-neoadjuvant-chemotherapy-in-locally-advanced-non-small-cell-lung-cancer-53099https://curecurrent.com/trials/endo-gia-stapler-with-endo-gia-reload-with-tri-staple-technology-in-a-pulmonary-resection-53100https://curecurrent.com/trials/indium-in-111-pentetreotide-in-treating-patients-with-refractory-cancer-53101https://curecurrent.com/trials/oxaliplatin-and-docetaxel-as-first-line-therapy-for-advanced-non-small-cell-lung-cancer-53102https://curecurrent.com/trials/patient-centred-integrated-palliative-care-pathways-in-advanced-cancer-and-chronic-disease-53103https://curecurrent.com/trials/cisplatin-vinorelbine-bevacizumab-followed-by-docetaxel-gemcitabine-bevacizumab-versus-the-cisplatin-docetaxel-bevacizum-53104https://curecurrent.com/trials/study-of-cisplatin-vinorelbine-cetuximab-as-first-line-treatment-of-advanced-non-small-cell-lung-cancer-flex-53105https://curecurrent.com/trials/molecular-markers-in-predicting-lung-cancer-development-using-tissue-samples-from-healthy-participants-53106https://curecurrent.com/trials/serum-and-exhaled-breath-condensate-maldi-ms-of-lung-cancer-spore-53107https://curecurrent.com/trials/emd-521873-plus-radiotherapy-in-non-small-cell-lung-cancer-nsclc-53108https://curecurrent.com/trials/prevention-of-atrial-fibrillation-in-patients-undergoing-thoracic-surgery-for-lung-cancer-53109https://curecurrent.com/trials/study-of-the-effect-of-cp-751-871-in-combination-with-gemcitabine-and-cisplatin-in-patients-with-advanced-non-small-cell-53110https://curecurrent.com/trials/cisplatin-irinotecan-and-bevacizumab-in-treating-patients-with-small-cell-lung-cancer-53111https://curecurrent.com/trials/a-dose-escalation-trial-of-pr610-treating-patients-with-solid-tumors-53112https://curecurrent.com/trials/erlotinib-and-cetuximab-with-or-without-bevacizumab-in-treating-patients-with-metastatic-or-unresectable-kidney-colorect-53113https://curecurrent.com/trials/photodynamic-therapy-using-hpph-in-treating-patients-with-advanced-non-small-cell-lung-cancer-that-blocks-the-air-passag-53114https://curecurrent.com/trials/ph-i-ii-nab-paclitaxel-carboplatin-w-concurrent-radiation-therapy-for-unresectable-stg-iii-nsclc-53115https://curecurrent.com/trials/blood-stem-cell-transplant-in-treating-patients-with-hematologic-cancer-53116https://curecurrent.com/trials/one-step-nucleic-acid-amplification-in-endobronchial-ultrasound-guided-needle-aspiration-samples-53117https://curecurrent.com/trials/carboplatin-paclitaxel-and-radiation-therapy-with-or-without-thalidomide-in-patients-with-stage-iii-non-small-cell-lung-53118https://curecurrent.com/trials/randomized-clinical-trial-of-8-weeks-pulmonary-rehabilitation-in-advanced-stage-lung-cancer-patients-with-copd-during-cy-53119https://curecurrent.com/trials/a-protocol-of-irinotecan-for-carcinoma-of-the-lung-53120https://curecurrent.com/trials/carboplatin-paclitaxel-and-bevacizumab-with-or-without-erlotinib-hydrochloride-in-treating-non-smokers-with-advanced-non-53121https://curecurrent.com/trials/sulindac-in-preventing-lung-cancer-in-current-or-former-smokers-with-bronchial-dysplasia-53122https://curecurrent.com/trials/a-phase-ii-study-to-assess-efficacy-of-combined-treatment-with-erlotinib-tarceva-and-silybin-phytosome-siliphos-in-patie-53123https://curecurrent.com/trials/rebeccamycin-analog-as-second-line-therapy-in-treating-patients-with-limited-stage-or-extensive-stage-small-cell-lung-ca-53124https://curecurrent.com/trials/chemotherapy-and-proton-radiation-for-the-treatment-of-locally-advanced-lung-cancer-53125https://curecurrent.com/trials/gemcitabine-and-imatinib-mesylate-in-treating-patients-with-recurrent-or-metastatic-non-small-cell-lung-cancer-53126https://curecurrent.com/trials/sorafenib-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53127https://curecurrent.com/trials/cancer-treatment-followed-by-surgery-for-early-stage-non-small-cell-lung-cancer-53128https://curecurrent.com/trials/a-study-of-pemetrexed-and-bevacizumab-for-participants-with-advanced-non-small-cell-cancer-53129https://curecurrent.com/trials/erlotinib-hydrochloride-with-or-without-cixutumumab-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-53130https://curecurrent.com/trials/sunitinib-in-treating-patients-with-advanced-malignant-pleural-mesothelioma-53131https://curecurrent.com/trials/national-lung-screening-trial-nlst-screening-53132https://curecurrent.com/trials/carboxyamidotriazole-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-53133https://curecurrent.com/trials/the-role-of-endobronchial-needle-aspiration-with-rapid-on-site-evaluation-in-the-diagnosis-of-central-malignant-lesions-53134https://curecurrent.com/trials/a-study-to-evaluate-foretinib-in-subjects-with-non-small-cell-lung-cancer-53135https://curecurrent.com/trials/a-double-blind-study-evaluating-ipi-504-and-docetaxel-in-patients-with-non-small-cell-lung-cancer-53136https://curecurrent.com/trials/breath-test-for-early-detection-of-lung-cancer-53137https://curecurrent.com/trials/efficacy-and-safety-study-of-bevacizumab-plus-chemotherapy-in-egfr-tki-resistant-non-squamous-non-small-cell-lung-cancer-53138https://curecurrent.com/trials/tirapazamine-combined-with-chemo-and-rt-in-limited-stage-small-cell-lung-cancer-53139https://curecurrent.com/trials/impact-of-a-gene-test-for-susceptibility-to-lung-cancer-in-smokers-53140https://curecurrent.com/trials/a-safety-efficacy-and-pharmacokinetic-study-of-siltuximab-cnto-328-in-participants-with-solid-tumors-53141https://curecurrent.com/trials/cisplatin-etoposide-and-bevacizumab-in-treating-patients-with-previously-untreated-extensive-stage-small-cell-lung-cance-53142https://curecurrent.com/trials/comparison-of-pleural-drainage-systems-on-reducing-pleural-effusion-formation-following-lung-resection-53143https://curecurrent.com/trials/assess-the-efficacy-of-whole-brain-radiation-therapy-in-lung-cancer-patients-with-brain-metastasis-53144https://curecurrent.com/trials/safety-and-efficacy-trial-of-ipilimumab-versus-pemetrexed-in-non-squamous-non-small-cell-lung-cancer-53145https://curecurrent.com/trials/r-gossypol-acetic-acid-in-treating-patients-with-recurrent-extensive-stage-small-cell-lung-cancer-53146https://curecurrent.com/trials/chemotherapy-followed-by-vaccine-therapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53147https://curecurrent.com/trials/sputum-cytology-in-screening-heavy-smokers-for-lung-cancer-53148https://curecurrent.com/trials/temozolomide-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-53149https://curecurrent.com/trials/trial-with-cetuximab-in-maintenance-therapy-after-platinum-based-chemotherapy-in-first-line-treatment-of-non-small-cell-53150https://curecurrent.com/trials/lungpoint-atv-for-biopsy-in-patients-undergoing-lobectomy-53151https://curecurrent.com/trials/the-impact-of-different-anticoagulant-therapy-on-hemorrhage-and-coagulation-after-thoracic-surgery-53152https://curecurrent.com/trials/immune-response-on-neoadjuvant-therapy-in-non-small-cell-lung-cancer-nsclc-53153https://curecurrent.com/trials/development-of-circulating-tumour-cell-molecular-diagnostics-using-a-novel-microfluidic-device-53154https://curecurrent.com/trials/nab-paclitaxel-as-second-line-therapy-in-locally-advanced-or-metastatic-squamous-lung-cancer-53155https://curecurrent.com/trials/biomarker-integrated-approach-of-targeted-therapy-for-lung-cancer-elimination-plus-external-beam-radiation-therapy-battl-53156https://curecurrent.com/trials/sunitinib-maintenance-therapy-after-induction-platinum-based-chemotherapy-in-patients-with-es-sclc-53157https://curecurrent.com/trials/diagnosis-and-treatment-strategies-in-patients-with-nsclc-with-or-without-egfr-mutations-53158https://curecurrent.com/trials/usefulness-of-blood-biomarkers-for-overall-survival-in-nsclc-53159https://curecurrent.com/trials/romidepsin-in-treating-patients-with-relapsed-small-cell-lung-cancer-53160https://curecurrent.com/trials/voriconazole-trough-plasma-levels-genetic-polymorphism-efficacy-safety-in-patients-with-hematologic-malignancy-53161https://curecurrent.com/trials/tumor-response-to-pemetrexed-disodium-in-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-enrolled-in-clin-53162https://curecurrent.com/trials/a-study-of-pemetrexed-and-cisplatin-in-non-small-cell-lung-cancer-53163https://curecurrent.com/trials/r-gossypol-acetic-acid-cisplatin-and-etoposide-in-treating-patients-with-advanced-solid-tumors-or-extensive-stage-small-53164https://curecurrent.com/trials/nsclc-burden-of-illness-study-53165https://curecurrent.com/trials/a-multi-centered-trial-evaluating-the-role-of-vitamin-d-metabolism-in-non-small-cell-lung-cancer-53166https://curecurrent.com/trials/vaccine-therapy-and-sargramostim-with-or-without-docetaxel-in-treating-patients-with-metastatic-lung-cancer-or-metastati-53167https://curecurrent.com/trials/a-study-to-assess-the-safety-and-preliminary-efficacy-of-pt-523-in-patients-with-advanced-non-small-cell-lung-cancer-nsc-53168https://curecurrent.com/trials/trial-comparing-cetuximab-with-pemetrexed-cetuximab-therapy-for-non-small-cell-lung-cancer-53169https://curecurrent.com/trials/erlotinib-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-53170https://curecurrent.com/trials/fast-track-rehabilitation-following-video-assisted-lung-segmentectomy-53171https://curecurrent.com/trials/pleurectomy-decortication-followed-by-intrathoracic-intraperitoneal-heated-cisplatin-for-malignant-pleural-mesothelioma-53172https://curecurrent.com/trials/extrapleural-pneumonectomy-with-intraoperative-intrathoracic-intraperitoneal-heated-cisplatin-with-amifostine-and-sodium-53173https://curecurrent.com/trials/single-arm-trial-of-bibw-2992-afatinib-in-demographically-and-genotypically-selected-nsclc-patients-53174https://curecurrent.com/trials/airway-epithelium-gene-expression-in-the-diagnosis-of-lung-cancer-aegis-clia-53175https://curecurrent.com/trials/safety-of-amg-706-plus-panitumumab-plus-gemcitabine-cisplatin-in-the-treatment-of-patients-with-advanced-cancer-53176https://curecurrent.com/trials/rituximab-for-prevention-of-chronic-gvhd-53177https://curecurrent.com/trials/a-non-interventional-survey-on-the-egfr-epidermal-growth-factor-receptor-mutation-status-in-completely-resected-chinese-53178https://curecurrent.com/trials/combined-liver-and-right-lung-resection-for-colorectal-metastases-by-means-of-j-shaped-thoracophrenolaparotomy-53179https://curecurrent.com/trials/lung-cancer-detection-by-measuring-monocyte-activity-53180https://curecurrent.com/trials/sunitinib-malate-in-treating-hiv-positive-patients-with-cancer-receiving-antiretroviral-therapy-53181https://curecurrent.com/trials/multimodal-hypoxia-imaging-and-intensity-modulated-radiotherapy-for-inoperable-non-small-cell-lung-cancer-53182https://curecurrent.com/trials/radiation-therapy-in-patients-with-limited-stage-small-cell-lung-cancer-in-complete-remission-53183https://curecurrent.com/trials/subcutaneous-alemtuzumab-campath-mabcampath-in-relapsed-refractory-b-cell-chronic-lymphocytic-leukemia-53184https://curecurrent.com/trials/bendamustine-as-second-line-therapy-in-treating-patients-with-relapsed-or-refractory-small-cell-lung-cancer-53185https://curecurrent.com/trials/a-dose-ascending-study-of-gemcitabine-elaidate-co-101-in-combination-with-cisplatin-53186https://curecurrent.com/trials/effects-of-carboplatin-and-gemcitabine-on-stage-iiib-pleural-effusion-and-stage-iv-lung-cancer-53187https://curecurrent.com/trials/bevacizumab-paclitaxel-carboplatin-and-radiation-therapy-to-the-chest-in-treating-patients-with-locally-advanced-non-sma-53188https://curecurrent.com/trials/biomarkers-to-detect-mesothelioma-early-in-patients-exposed-to-asbestos-or-vermiculite-53189https://curecurrent.com/trials/fondaparinux-arixtra-with-chemotherapy-for-advanced-non-small-cell-lung-cancer-53190https://curecurrent.com/trials/efficacy-and-safety-of-a-sunscreen-against-porfimer-sodium-induced-phototoxicity-to-visible-light-53191https://curecurrent.com/trials/a-study-to-evaluate-tarceva-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-53192https://curecurrent.com/trials/biweekly-schedule-of-docetaxel-and-cisplatin-in-high-risk-patients-with-unresectable-non-small-cell-lung-cancer-nsclc-53193https://curecurrent.com/trials/study-to-see-if-microcoil-insertion-reduces-the-rate-of-open-thoracotomy-for-removal-of-lung-nodules-53194https://curecurrent.com/trials/identification-by-microarrays-of-the-risks-of-metastatic-relapse-toxicity-and-resistance-to-adjuvant-chemotherapy-in-com-53195https://curecurrent.com/trials/tax-first-line-chemotherapy-with-different-doses-and-then-maintenance-therapy-53196https://curecurrent.com/trials/dendritic-cell-based-immunotherapy-combined-with-low-dose-cyclophosphamide-in-patients-with-malignant-mesothelioma-53197https://curecurrent.com/trials/effectiveness-of-nursing-case-management-for-lung-cancer-patients-53198https://curecurrent.com/trials/afatinib-plus-nimotuzumb-for-nsclc-53199https://curecurrent.com/trials/theranostic-tool-during-erlotinib-treatment-in-non-small-cell-lung-cancer-patient-53200https://curecurrent.com/trials/the-contribution-of-induced-glycolysis-to-the-exhaled-volatile-organic-compounds-vocs-signature-in-lung-cancer-53201https://curecurrent.com/trials/intermittent-and-maintenance-of-erlotinib-in-combination-with-pemetrexed-carboplatin-in-b-iv-non-small-cell-lung-cancer-53202https://curecurrent.com/trials/icotinib-combined-with-wbrt-for-nsclc-patients-with-brain-metastases-and-egfr-mutation-53203https://curecurrent.com/trials/dose-escalation-of-icotinib-in-previously-treated-patients-with-routine-dose-53204https://curecurrent.com/trials/safety-and-efficacy-study-of-icotinb-in-non-small-cell-lung-cancer-nsclc-patients-53205https://curecurrent.com/trials/combination-chemotherapy-with-or-without-bevacizumab-in-treating-patients-with-malignant-mesothelioma-53206https://curecurrent.com/trials/combination-of-weekly-chest-radiotherapy-and-oral-navelbine-for-the-palliation-of-advanced-non-small-cell-lung-cancer-a-53207https://curecurrent.com/trials/once-weekly-radiation-for-lung-cancer-with-chemotherapy-53208https://curecurrent.com/trials/safety-study-of-individual-paclitaxel-dose-adjustment-based-on-pharmacokinetics-in-non-small-cell-lung-cancer-nsclc-53209https://curecurrent.com/trials/outlook-an-intervention-to-improve-quality-of-life-in-serious-illness-53210https://curecurrent.com/trials/dose-escalating-study-of-the-safety-and-efficacy-of-patupilone-q3w-in-patients-with-non-small-cell-lung-cancer-53211https://curecurrent.com/trials/treatment-of-outpatients-with-severe-asthma-and-moderate-or-severe-major-depressive-disorder-53212https://curecurrent.com/trials/scot-registry-small-cell-lung-cancer-treatment-and-outcome-53213https://curecurrent.com/trials/a-pilot-phase-2-trial-of-the-immunogenicity-and-safety-of-gi-4000-an-inactivated-recombinant-s-cerevisiae-expressing-mut-53214https://curecurrent.com/trials/hypo-hyperfractionated-chest-radiation-for-non-small-cell-lung-cancer-with-taxotere-xeloda-combination-chemotherapy-53215https://curecurrent.com/trials/positron-emission-tomography-scan-and-ct-scan-in-planning-radiation-therapy-for-patients-with-stage-ii-or-stage-iii-non-53216https://curecurrent.com/trials/gefitinib-usage-and-outcomes-in-routine-treatment-53217https://curecurrent.com/trials/establishment-and-characterization-of-patient-derived-non-small-cell-lung-cancer-xenografts-and-cell-cultures-53218https://curecurrent.com/trials/customizing-first-line-chemotherapy-in-advanced-non-small-cell-lung-cancer-53219https://curecurrent.com/trials/oral-hycamtin-plus-whole-brain-radiation-therapy-in-treatment-of-brain-metastases-resulting-from-non-small-lung-cancer-53220https://curecurrent.com/trials/dose-escalation-study-of-rad001-in-combination-w-chemotherapy-radiation-in-patients-with-nsclc-53221https://curecurrent.com/trials/study-of-gemcitabine-maintenance-treatment-in-patients-with-extensive-sclc-patients-53222https://curecurrent.com/trials/changes-in-brain-structure-related-to-systemic-chemotherapy-treatment-a-prospective-study-in-individuals-diagnosed-with-53223https://curecurrent.com/trials/safety-study-combined-modality-treatment-for-non-small-cell-lung-cancer-53224https://curecurrent.com/trials/two-regimens-of-docetaxel-in-treating-patients-who-have-not-received-chemotherapy-for-unresectable-stage-iiib-or-stage-i-53225https://curecurrent.com/trials/safety-and-exploratory-efficacy-of-kanglaite-injection-in-non-small-cell-lung-cancer-53226https://curecurrent.com/trials/erlotinib-monotherapy-versus-docetaxel-and-cisplatin-as-neoadjuvant-therapy-in-patients-of-stageiiia-lung-ca-53227https://curecurrent.com/trials/dasatinib-in-advanced-non-small-cell-lung-cancer-nscl-with-ex-vivo-and-in-vivo-assessment-of-tumor-target-modulation-53228https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53229https://curecurrent.com/trials/photodynamic-therapy-pdt-with-temoporfin-for-non-resectable-non-small-cell-lung-cancer-53230https://curecurrent.com/trials/a-study-of-predictive-and-prognostic-markers-in-patients-with-non-small-cell-lung-cancer-53231https://curecurrent.com/trials/genetic-polymorphisms-in-ugt1a6-and-ugt2b7-in-asian-population-association-with-lung-cancer-phenotype-53232https://curecurrent.com/trials/virtual-bronchoscopy-vb-vs-endobronchial-ultrasound-ebus-guided-mediastinal-sampling-53233https://curecurrent.com/trials/phase-i-and-ii-study-of-stereotactic-body-radiotherapy-in-medically-unresectable-patients-with-stage-1-nsclc-53234https://curecurrent.com/trials/carboplatin-and-paclitaxel-with-or-without-cp-751-871-an-igf-1r-inhibitor-for-advanced-nsclc-of-squamous-large-cell-and-53235https://curecurrent.com/trials/bexarotene-tretinoin-and-combination-chemotherapy-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-ca-53236https://curecurrent.com/trials/cryospray-ablation-of-surgical-resection-specimens-to-determine-safety-and-histological-effect-in-the-lung-53237https://curecurrent.com/trials/combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53238https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53239https://curecurrent.com/trials/topotecan-in-treating-patients-with-relapsed-small-cell-lung-cancer-53240https://curecurrent.com/trials/phase-ii-study-of-combination-of-paclitaxel-poliglumex-and-alimta-for-advanced-non-small-cell-lung-cancer-nsclc-53241https://curecurrent.com/trials/temozolomide-in-treating-patients-with-metastatic-non-small-cell-lung-cancer-53242https://curecurrent.com/trials/low-dose-nilotinib-and-imatinib-combination-in-chronic-myeloid-leukemia-patients-with-failure-suboptimal-response-or-tre-53243https://curecurrent.com/trials/t138067-in-treating-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-that-has-not-responded-to-pr-53244https://curecurrent.com/trials/topotecan-and-paclitaxel-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-other-advanced-solid-tumors-53245https://curecurrent.com/trials/vinorelbine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53246https://curecurrent.com/trials/surgery-chemotherapy-and-radiation-therapy-in-treating-patients-with-peritoneal-cancer-53247https://curecurrent.com/trials/lometrexol-plus-folic-acid-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53248https://curecurrent.com/trials/high-dose-combination-chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-lung-cance-53249https://curecurrent.com/trials/docetaxel-with-or-without-oblimersen-in-treating-patients-with-non-small-cell-lung-cancer-53250https://curecurrent.com/trials/a-phase-ii-trial-of-afatinib-bibw-2992-in-third-line-treatment-for-patients-with-stage-iiib-iv-adenocarcinoma-of-the-lun-53251https://curecurrent.com/trials/cik-cell-transfusion-plus-gefitinib-as-second-or-third-line-treatment-for-advanced-adenocarcinoma-non-small-cell-lung-ca-53252https://curecurrent.com/trials/a-trial-comparing-safety-and-efficacy-of-carboplatin-and-paclitaxel-plus-or-minus-sorafenib-bay43-9006-in-chemonaive-pat-53253https://curecurrent.com/trials/the-effect-of-different-i-e-ratio-on-gas-exchange-of-patients-undergoing-one-lung-ventilation-for-lung-surgery-53254https://curecurrent.com/trials/intrapleural-administration-of-bevacizumab-versus-endostar-for-pleural-effusions-in-nsclc-53255https://curecurrent.com/trials/implantation-of-markers-for-the-radiotherapy-of-lung-cancer-patients-53256https://curecurrent.com/trials/continuation-of-tki-with-or-without-chemotherapy-beyond-gradual-progression-53257https://curecurrent.com/trials/radiation-therapy-plus-combination-chemotherapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-53258https://curecurrent.com/trials/neoadjuvant-chemotherapy-of-nanoparticle-albumin-bound-paclitaxel-in-lung-cancer-53259https://curecurrent.com/trials/zd-1839-plus-chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-53260https://curecurrent.com/trials/afatinib-in-combination-with-cisplatin-or-carboplatin-pemetrexed-in-patients-with-egfr-mutant-lung-cancers-undergoing-de-53261https://curecurrent.com/trials/docetaxel-and-vinorelbine-plus-filgrastim-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53262https://curecurrent.com/trials/zd0473-in-treating-patients-with-progressive-or-relapsed-non-small-lung-cancer-53263https://curecurrent.com/trials/zd-1839-plus-combination-chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-53264https://curecurrent.com/trials/vinorelbine-and-or-gemcitabine-in-treating-older-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53265https://curecurrent.com/trials/radiation-therapy-in-preventing-metastatic-cancer-in-patients-who-have-diagnostic-procedures-to-identify-malignant-mesot-53266https://curecurrent.com/trials/combination-chemotherapy-followed-by-radiation-therapy-in-patients-with-small-cell-lung-cancer-53267https://curecurrent.com/trials/radiation-therapy-with-or-without-vinorelbine-and-cisplatin-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-53268https://curecurrent.com/trials/volociximab-and-erlotinib-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-53269https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53270https://curecurrent.com/trials/combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-stage-ii-or-stage-iii-non-small-cell-lung-cance-53271https://curecurrent.com/trials/quality-of-life-in-patients-who-are-receiving-either-vinorelbine-gemcitabine-and-docetaxel-or-paclitaxel-and-carboplatin-53272https://curecurrent.com/trials/docetaxel-in-treating-patients-with-non-small-cell-lung-cancer-53273https://curecurrent.com/trials/safety-study-of-adjuvant-docetaxel-carboplatin-treatment-for-resected-lung-cancer-53274https://curecurrent.com/trials/combination-chemotherapy-followed-by-radiation-therapy-with-or-without-paclitaxel-in-treating-patients-with-unresectable-53275https://curecurrent.com/trials/mistletoe-in-treating-patients-with-advanced-non-small-cell-lung-cancer-who-are-receiving-palliative-chemotherapy-53276https://curecurrent.com/trials/standard-therapy-given-with-or-without-combination-chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-53277https://curecurrent.com/trials/marimastat-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53278https://curecurrent.com/trials/survivorship-care-planning-in-patients-with-colorectal-or-non-small-cell-lung-cancer-53279https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53280https://curecurrent.com/trials/comparison-of-cvats-segmentectomy-versus-lobectomy-for-lung-adenocarcinoma-in-situ-and-with-microinvasion-53281https://curecurrent.com/trials/a-study-comparing-two-different-chemotherapy-types-in-chinese-patients-with-advanced-non-small-cell-lung-cancer-53282https://curecurrent.com/trials/effect-of-remote-ischemic-preconditioning-on-lung-injury-after-pulmonary-resection-53283https://curecurrent.com/trials/efficacy-of-egfr-tkis-in-patients-with-rare-egfr-mutated-nsclc-53284https://curecurrent.com/trials/dysregulation-of-the-c-ebpa-pathway-in-human-lung-cancer-and-search-for-new-biomarkers-and-or-therapeutic-targets-53285https://curecurrent.com/trials/a-retrospective-study-of-biomarkers-in-non-small-cell-lung-cancer-53286https://curecurrent.com/trials/a-study-of-serum-protein-profiling-in-patients-with-non-small-cell-lung-cancer-treated-with-gefitinib-or-erlotinib-53287https://curecurrent.com/trials/a-retrospective-molecular-epidemiology-study-in-singapore-patients-with-advanced-non-small-cell-lung-cancer-nsclc-of-ade-53288https://curecurrent.com/trials/detection-of-egfr-mutations-in-the-blood-of-patients-with-non-small-cell-lung-cancer-a-feasibility-study-53289https://curecurrent.com/trials/gefitinib-500mg-versus-250mg-in-patients-with-nsclc-with-stable-disease-after-a-month-treatment-of-gefitinib-250mg-53290https://curecurrent.com/trials/ercc1-targeted-trial-53291https://curecurrent.com/trials/a-study-of-pre-operative-treatment-of-newly-diagnosed-surgically-resectable-osteosarcoma-with-doxorubicin-ifosfamide-eto-53292https://curecurrent.com/trials/screening-non-small-cell-lung-cancer-with-bone-metastasis-and-efficacy-and-safety-research-of-receiving-bisphosphonates-53293https://curecurrent.com/trials/hydroxychloroquine-and-gefitinib-to-treat-lung-cancer-53294https://curecurrent.com/trials/efficacy-and-safety-study-of-zometa-in-treatment-of-high-level-ntx-non-small-cell-lung-cancer-with-bone-metastasis-53295https://curecurrent.com/trials/enumeration-of-circulating-tumour-cells-ctcs-in-patients-with-advanced-solid-malignancy-using-complementary-metal-oxide-53296https://curecurrent.com/trials/evaluating-endostatin-plus-tc-regimen-in-secondary-malignant-neoplasm-of-liver-using-contrast-enhancement-ultrasonograph-53297https://curecurrent.com/trials/cik-cell-transfusion-plus-chemotherapy-as-adjuvant-therapy-for-stage-ib-iiia-non-small-cell-lung-cancer-nsclc-53298https://curecurrent.com/trials/apatinib-in-the-treatment-of-advanced-non-squamous-non-small-cell-lung-cancer-53299https://curecurrent.com/trials/the-synergistic-metastases-annihilation-with-radiotherapy-and-docetaxel-taxotere-smart-trial-for-non-small-cell-lung-can-53300https://curecurrent.com/trials/analysis-of-plasma-tumor-dna-in-lung-cancer-patients-53301https://curecurrent.com/trials/study-of-axl1717-compared-to-docetaxel-to-treat-squamous-cell-carcinoma-or-adenocarcinoma-of-the-lung-53302https://curecurrent.com/trials/erlotinib-intercalated-with-chemotherapy-versus-erlotinib-as-first-line-treatment-in-stage-iiib-iv-nsclc-patients-with-e-53303https://curecurrent.com/trials/nitrocamptothecin-in-treating-patients-with-recurrent-non-small-cell-lung-cancer-53304https://curecurrent.com/trials/docetaxel-cisplatin-and-amifostine-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53305https://curecurrent.com/trials/docetaxel-plus-carboplatin-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53306https://curecurrent.com/trials/surgery-with-or-without-preoperative-chemotherapy-in-treating-patients-with-resectable-non-small-cell-lung-cancer-53307https://curecurrent.com/trials/emergency-radiotherapy-in-metastatic-spinal-cord-compression-of-patients-with-non-small-cell-lung-cancer-53308https://curecurrent.com/trials/paclitaxel-in-treating-patients-with-recurrent-or-refractory-non-small-cell-lung-cancer-53309https://curecurrent.com/trials/amifostine-to-prevent-side-effects-in-patients-who-are-receiving-chemotherapy-and-radiation-therapy-for-limited-stage-sm-53310https://curecurrent.com/trials/comparison-of-postoperative-adjuvant-chemotherapy-with-without-rh-endostatin-on-non-small-cell-lung-cancer-in-phase-b-53311https://curecurrent.com/trials/a-study-comparing-etoposide-cisplatin-with-irinotecan-cisplatin-to-treat-extensive-disease-small-lung-cancer-53312https://curecurrent.com/trials/determinants-of-intensity-of-care-of-lung-cancer-patients-with-organ-failure-53313https://curecurrent.com/trials/gene-mutations-in-non-small-cell-lung-cancer-cells-53314https://curecurrent.com/trials/green-tea-or-polyphenon-e-in-preventing-lung-cancer-in-former-smokers-with-chronic-obstructive-pulmonary-disease-53315https://curecurrent.com/trials/pilot-study-of-a-geriatric-intervention-after-colorectal-and-lung-cancer-surgery-53316https://curecurrent.com/trials/study-of-telintra-for-treatment-of-chemotherapy-induced-neutropenia-in-patients-with-non-small-cell-lung-cancer-53317https://curecurrent.com/trials/chemotherapy-plus-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-cannot-be-surgic-53318https://curecurrent.com/trials/t-regulatory-lymphocytes-treg-depletion-for-cancer-treatment-efficacy-and-safety-study-53319https://curecurrent.com/trials/s0220-chemoradiotherapy-followed-by-surgery-and-docetaxel-in-treating-patients-with-pancoast-tumors-53320https://curecurrent.com/trials/immune-response-and-safety-of-hs110-vaccine-in-combination-with-erlotinib-in-patients-with-non-small-cell-lung-cancer-53321https://curecurrent.com/trials/prophylaxis-of-venous-thromboembolism-in-advanced-lung-cancer-53322https://curecurrent.com/trials/study-of-use-of-ctc-in-nsclc-53323https://curecurrent.com/trials/gemcitabine-plus-paclitaxel-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-other-solid-tumor-53324https://curecurrent.com/trials/amino-acid-tracer-facbc-positron-emission-tomography-for-lung-nodule-53325https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-53326https://curecurrent.com/trials/nodal-upstaging-in-vats-anatomical-resections-for-nsclc-53327https://curecurrent.com/trials/study-of-vorinostat-and-gefitinib-in-relapsed-or-refractory-patients-with-advanced-non-small-cell-carcinoma-nsclc-53328https://curecurrent.com/trials/dose-escalating-study-with-bay43-9006-with-carboplatin-paclitaxel-and-bevacizumab-in-untreated-stage-iiib-non-small-cell-53329https://curecurrent.com/trials/treatment-of-early-stage-lung-cancer-by-vats-versus-open-lobectomy-53330https://curecurrent.com/trials/a-study-of-ag-013736-axitinib-or-bevacizumab-avastin-in-combination-with-paclitaxel-and-carboplatin-in-patients-with-adv-53331https://curecurrent.com/trials/first-line-iressa-versus-carboplatin-paclitaxel-in-asia-53332https://curecurrent.com/trials/vnp40101m-in-treating-patients-with-relapsed-or-refractory-locally-advanced-or-metastatic-small-cell-lung-cancer-53333https://curecurrent.com/trials/diagnosis-and-treatment-planning-in-patients-suspected-of-having-lung-cancer-53334https://curecurrent.com/trials/onconase-plus-doxorubicin-versus-doxorubicin-alone-for-patients-with-malignant-pleural-or-peritoneal-mesothelioma-who-ha-53335https://curecurrent.com/trials/gossypol-combined-with-docetaxel-and-cisplatin-scheme-in-advanced-non-small-cell-lung-cancers-with-ape1-high-expression-53336https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-53337https://curecurrent.com/trials/3-ap-and-gemcitabine-in-treating-patients-with-metastatic-non-small-cell-lung-cancer-53338https://curecurrent.com/trials/ins316-compared-with-saline-for-sputum-collection-in-diagnosing-lung-cancer-53339https://curecurrent.com/trials/biological-therapy-in-previously-treated-patients-with-non-small-cell-lung-cancer-53340https://curecurrent.com/trials/abi-007-in-treating-patients-with-chemotherapy-na-ve-stage-iv-non-small-cell-lung-cancer-53341https://curecurrent.com/trials/phase-2b-study-of-cetuximab-with-platinum-based-chemo-as-first-line-treatment-of-recurrent-or-advanced-nsclc-53342https://curecurrent.com/trials/prophylactic-evozac-calming-skin-spray-for-egfr-tkis-associated-rash-eruption-in-nsclc-53343https://curecurrent.com/trials/study-of-combination-of-metronomic-oral-vinorelbine-and-sorafenib-in-patients-with-advanced-non-small-cell-lung-cancer-53344https://curecurrent.com/trials/radiation-therapy-plus-combination-chemotherapy-in-treating-patients-with-small-cell-lung-cancer-53345https://curecurrent.com/trials/radiation-therapy-using-3-dimensional-treatment-planning-in-patients-with-non-small-cell-lung-cancer-53346https://curecurrent.com/trials/trial-of-motexafin-gadolinium-and-pemetrexed-alimta-for-second-line-treatment-in-patients-with-non-small-cell-lung-cance-53347https://curecurrent.com/trials/lapatinib-and-cetuximab-in-patients-with-solid-tumors-53348https://curecurrent.com/trials/retrospective-study-in-a-nsclc-m-p-53349https://curecurrent.com/trials/combination-study-of-cp-751-871-with-paclitaxel-and-carboplatin-in-advanced-lung-cancer-53350https://curecurrent.com/trials/bay43-9006-phase-ii-study-in-non-small-cell-lung-carcinoma-nsclc-53351https://curecurrent.com/trials/thoracoscopic-lobectomy-using-nonintubated-anesthesia-versus-intubated-general-anesthesia-for-lung-cancer-patients-53352https://curecurrent.com/trials/disease-specific-questionnaire-in-assessing-quality-of-life-in-patients-with-gastrointestinal-related-neuroendocrine-tum-53353https://curecurrent.com/trials/a-study-in-patients-with-non-small-cell-lung-cancer-to-test-if-erlotinib-plus-su011248-is-better-than-erlotinib-alone-53354https://curecurrent.com/trials/epidemiological-and-scientific-evaluation-of-egfr-mutation-status-in-patients-with-newly-diagnosed-locally-advanced-or-m-53355https://curecurrent.com/trials/feasibility-of-exercise-with-post-op-lung-cancer-patients-53356https://curecurrent.com/trials/chemotherapy-of-elderly-patients-with-non-small-cell-lung-cancer-nsclc-53357https://curecurrent.com/trials/emd-273066-in-patients-with-recurrent-epcam-positive-ovarian-prostate-colorectal-or-non-small-cell-lung-cancers-when-fir-53358https://curecurrent.com/trials/dose-schedule-finding-trial-of-romiplostim-for-chemotherapy-induced-thrombocytopenia-cit-in-non-small-cell-lung-cancer-n-53359https://curecurrent.com/trials/early-lung-cancer-detection-in-patients-with-sputum-cytology-and-autofluorescence-bronchoscopy-in-people-at-high-risk-of-53360https://curecurrent.com/trials/interleukin-2-combined-with-monoclonal-antibody-therapy-in-treating-patients-with-kidney-bladder-or-lung-cancer-that-has-53361https://curecurrent.com/trials/hepatic-arterial-infusion-of-melphalan-with-hepatic-perfusion-in-treating-patients-with-unresectable-liver-cancer-53362https://curecurrent.com/trials/safety-of-adding-imo-2055-to-erlotinib-bevacizumab-in-2nd-line-treatment-for-patients-with-nsclc-53363https://curecurrent.com/trials/the-roles-of-age-comorbidity-and-telomere-length-in-lung-cancer-treatment-and-prognosis-53364https://curecurrent.com/trials/the-effects-of-azd2171-in-patients-with-non-small-cell-lung-cancer-or-head-neck-cancer-53365https://curecurrent.com/trials/ts-stratified-chemotherapy-and-vegf-inhibition-in-non-squamous-non-small-cell-lung-cancer-stage-iv-53366https://curecurrent.com/trials/endobronchial-valves-in-persistent-air-leak-53367https://curecurrent.com/trials/marijuana-for-cancer-pain-53368https://curecurrent.com/trials/evaluate-the-utility-of-the-prolung-test-as-adjunctive-to-ct-scan-in-the-diagnosis-of-lung-cancer-53369https://curecurrent.com/trials/comprehensive-geriatric-assessment-and-complications-following-lung-resection-for-lung-cancer-53370https://curecurrent.com/trials/imatinib-mesylate-in-treating-patients-with-recurrent-small-cell-lung-cancer-53371https://curecurrent.com/trials/lung-cancer-location-a-repository-53372https://curecurrent.com/trials/elderly-independent-patients-with-non-small-cell-lung-cancer-nsclc-53373https://curecurrent.com/trials/study-to-assess-safety-tolerability-efficacy-of-gefitinib-versus-docetaxel-in-locally-advanced-or-metastatic-non-small-c-53374https://curecurrent.com/trials/elderly-dependent-patients-with-non-small-cell-lung-cancer-nsclc-53375https://curecurrent.com/trials/predictive-factors-for-exacerbation-outcome-in-severe-refractory-asthmatics-53376https://curecurrent.com/trials/decitabine-and-valproic-acid-in-treating-patients-with-non-small-cell-lung-cancer-53377https://curecurrent.com/trials/a-multi-center-study-of-pet-imaging-with-f-18-flt-f-18-fdg-in-cancer-patients-for-treatment-evaluation-53378https://curecurrent.com/trials/sar240550-in-combination-with-gemcitabine-cisplatin-in-non-small-cell-lung-cancer-53379https://curecurrent.com/trials/pulmonary-artery-energy-sealing-for-vats-procedure-53380https://curecurrent.com/trials/gemcitabine-plus-supportive-care-in-treating-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-53381https://curecurrent.com/trials/vaccine-therapy-and-ganciclovir-in-treating-patients-with-mesothelioma-53382https://curecurrent.com/trials/metronomic-cyclophosphamide-in-combination-with-standard-chemotherapy-for-squamous-cell-lung-carcinoma-53383https://curecurrent.com/trials/hospitalization-rates-of-patients-with-non-small-cell-lung-cancer-treated-with-gemcitabine-and-either-cisplatin-or-carbo-53384https://curecurrent.com/trials/celecoxib-and-erlotinib-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53385https://curecurrent.com/trials/biomarkers-in-predicting-treatment-response-in-samples-from-patients-with-early-stage-non-small-cell-lung-cancer-previou-53386https://curecurrent.com/trials/paclitaxel-and-carboplatin-chemotherapy-compared-with-standard-chemotherapy-in-treating-patients-with-stage-iii-or-stage-53387https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-stage-i-ii-or-iiia-non-small-cell-lung-cancer-that-has-been-surgicall-53388https://curecurrent.com/trials/staple-line-reinforcement-for-prevention-of-pulmonary-air-leakage-53389https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-who-have-extensive-stage-small-cell-lung-cancer-53390https://curecurrent.com/trials/chemotherapy-followed-by-peripheral-stem-cell-or-bone-marrow-transplant-compared-with-chemotherapy-alone-in-treating-pat-53391https://curecurrent.com/trials/combination-chemotherapy-followed-by-surgery-in-treating-infants-with-newly-diagnosed-neuroblastoma-53392https://curecurrent.com/trials/phosphorus-32-plus-radiation-therapy-and-chemotherapy-in-treating-patients-with-stage-ii-or-stage-iii-non-small-cell-lun-53393https://curecurrent.com/trials/vinorelbine-gemcitabine-and-docetaxel-compared-with-paclitaxel-and-carboplatin-in-treating-patients-with-advanced-non-sm-53394https://curecurrent.com/trials/screening-to-predict-weight-loss-in-patients-with-cancer-53395https://curecurrent.com/trials/combination-chemotherapy-in-treating-infants-with-newly-diagnosed-neuroblastoma-53396https://curecurrent.com/trials/amg-706-and-gemcitabine-in-treating-patients-with-advanced-solid-tumors-or-lymphoma-53397https://curecurrent.com/trials/hydroxyurea-plus-combination-chemotherapy-in-patients-with-non-small-cell-lung-cancer-53398https://curecurrent.com/trials/a-study-of-biib022-in-combination-with-paclitaxel-and-carboplatin-in-subjects-with-non-small-cell-lung-cancer-53399https://curecurrent.com/trials/vx-710-doxorubicin-and-vincristine-for-the-treatment-of-patients-with-recurrent-small-cell-lung-cancer-53400https://curecurrent.com/trials/serum-plasma-dna-and-tissue-bank-in-chronic-obstructive-pulmonary-disease-and-lung-cancer-53401https://curecurrent.com/trials/qol-stereotactic-radiosurgery-temozolomide-erlotinib-rx-of-1-3-brain-metastases-in-nsclc-53402https://curecurrent.com/trials/chemotherapy-and-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-53403https://curecurrent.com/trials/study-of-f-18-hx4-positron-emission-tomography-pet-as-a-tool-to-detect-hypoxia-in-tumors-53404https://curecurrent.com/trials/an-open-label-study-of-bibw-2992-afatinib-in-advanced-non-small-cell-lung-cancer-patients-pre-treated-with-erlotinib-or-53405https://curecurrent.com/trials/combination-of-cisplatin-docetaxel-and-bevacizumab-in-patients-with-non-small-cell-lung-carcinoma-nsclc-53406https://curecurrent.com/trials/influence-of-n-acetylcysteine-on-morbidity-oxygenation-and-cytokine-levels-in-partial-or-total-esophagectomy-for-cancer-53407https://curecurrent.com/trials/hypoxia-guided-radiotherapy-with-cisplatin-etoposide-in-stage-i-iii-small-cell-lung-cancer-sclc-53408https://curecurrent.com/trials/a-study-in-non-squamous-non-small-cell-lung-cancer-in-asian-patients-53409https://curecurrent.com/trials/study-of-how-caregivers-help-patients-cope-with-respiratory-and-other-symptoms-caused-by-lung-cancer-53410https://curecurrent.com/trials/dexamethasone-and-supportive-care-with-or-without-whole-brain-radiation-therapy-in-treating-patients-with-non-small-cell-53411https://curecurrent.com/trials/observational-study-of-the-decision-making-towards-clinical-trials-in-cancer-patients-53412https://curecurrent.com/trials/study-of-episodic-breathlessness-in-patients-with-lung-cancer-or-other-advanced-disease-53413https://curecurrent.com/trials/standard-medical-care-or-urgent-chest-x-ray-in-diagnosing-lung-cancer-in-smokers-with-chest-symptoms-who-are-older-than-53414https://curecurrent.com/trials/gemcitabine-in-combination-with-either-cisplatin-or-carboplatin-in-treating-patients-with-stage-iii-or-stage-iv-non-smal-53415https://curecurrent.com/trials/biomarkers-for-early-detection-of-lung-cancer-in-patients-with-lung-cancer-participants-at-high-risk-for-developing-lung-53416https://curecurrent.com/trials/phase-i-ii-trial-of-rad001-plus-docetaxel-in-patients-with-metastatic-or-recurrent-non-small-cell-lung-cancer-53417https://curecurrent.com/trials/extensive-small-cell-lung-cancer-treatment-using-an-investigational-drug-plus-chemotherapy-in-chemotherapy-naive-adults-53418https://curecurrent.com/trials/phase-ii-trial-of-regimen-for-stage-iii-n2-nsclc-using-induction-treatment-followed-by-resection-53419https://curecurrent.com/trials/sorafenib-treatment-in-non-small-cell-lung-cancer-after-failure-of-epidermal-growth-factor-receptor-tyrosine-kinase-inhi-53420https://curecurrent.com/trials/modafinil-for-the-treatment-of-fatigue-in-lung-cancer-v9-0-53421https://curecurrent.com/trials/multiple-vaccine-therapy-in-treating-patients-with-non-small-cell-lung-cancer-53422https://curecurrent.com/trials/peptide-vaccine-targeting-to-cancer-specific-antigen-combined-with-anti-angiogenic-peptide-antigen-in-treating-patients-53423https://curecurrent.com/trials/comparison-of-standard-of-care-or-treatment-on-protocol-53424https://curecurrent.com/trials/differences-in-the-presentation-outcome-and-response-to-treatment-between-never-smokers-and-smokers-with-nsclc-53425https://curecurrent.com/trials/effect-of-exercise-training-on-angiogenesis-and-cachexia-in-lung-cancer-patients-53426https://curecurrent.com/trials/drug-delivery-and-toxicities-of-adjuvant-chemotherapy-in-resected-ncslc-53427https://curecurrent.com/trials/vaccine-therapy-plus-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-that-has-been-completely-rem-53428https://curecurrent.com/trials/paclitaxel-and-carboplatin-with-or-without-nitroglycerin-in-treating-patients-with-previously-untreated-stage-iii-or-sta-53429https://curecurrent.com/trials/gemcitabine-and-cisplatin-before-or-after-surgery-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-canc-53430https://curecurrent.com/trials/study-of-blood-and-tissue-samples-in-predicting-response-to-second-line-therapy-using-erlotinib-hydrochloride-or-chemoth-53431https://curecurrent.com/trials/studying-patterns-causes-and-control-of-disease-in-patients-with-lung-cancer-in-the-north-trent-england-region-53432https://curecurrent.com/trials/paclitaxel-carboplatin-and-gefitinib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53433https://curecurrent.com/trials/treatment-outcome-and-quality-of-life-in-patients-with-pediatric-extra-cranial-germ-cell-tumors-previously-treated-on-cl-53434https://curecurrent.com/trials/a-study-of-mapatumumab-in-combination-with-paclitaxel-and-carboplatin-in-subjects-with-non-small-cell-lung-cancer-53435https://curecurrent.com/trials/the-effect-of-direct-referral-for-fast-ct-scan-in-early-lung-cancer-detection-in-general-practice-53436https://curecurrent.com/trials/palliative-therapy-with-or-without-chemotherapy-in-treating-patients-with-malignant-mesothelioma-53437https://curecurrent.com/trials/optimization-of-treatment-of-advanced-nonsmall-cell-lung-cancer-using-radiotherapy-and-chemotherapy-53438https://curecurrent.com/trials/active-symptom-control-with-or-without-chemotherapy-in-treating-patients-with-malignant-pleural-mesothelioma-53439https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53440https://curecurrent.com/trials/duet-trs-used-in-pulmonary-resections-53441https://curecurrent.com/trials/vegf-signaling-promotes-cell-growth-and-metastasis-in-intrahepatic-cholangiocarcinoma-in-a-vegf-receptor-mediated-pathwa-53442https://curecurrent.com/trials/study-of-trm-1-trail-r1-monoclonal-antibody-in-subjects-with-relapsed-or-refractory-non-small-cell-lung-cancer-nsclc-53443https://curecurrent.com/trials/amg-102-pemetrexed-disodium-and-cisplatin-in-treating-patients-with-malignant-pleural-mesothelioma-53444https://curecurrent.com/trials/cisplatin-plus-vinorelbine-with-or-without-tirapazamine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-53445https://curecurrent.com/trials/image-discovering-early-lung-cancer-project-53446https://curecurrent.com/trials/radiation-therapy-to-the-brain-or-observation-in-preventing-brain-metastases-in-patients-with-advanced-non-small-cell-lu-53447https://curecurrent.com/trials/ebus-gs-tblb-with-or-without-fluoroscopy-for-the-diagnosis-of-ppls-53448https://curecurrent.com/trials/a-phase-2-study-of-tarceva-for-untreated-good-prognosis-patients-with-advanced-non-small-cell-lung-cancer-53449https://curecurrent.com/trials/pulmonary-surgery-and-protective-mechanical-ventilation-53450https://curecurrent.com/trials/combination-chemotherapy-followed-by-surgery-in-treating-patients-with-stage-iiia-non-small-cell-lung-cancer-53451https://curecurrent.com/trials/a-phase-i-ii-study-of-tivozanib-and-erlotinib-as-initial-treatment-for-metastatic-non-small-cell-lung-cancer-assigned-by-53452https://curecurrent.com/trials/ge-healthcare-volumerad-lung-nodule-detection-study-53453https://curecurrent.com/trials/trial-of-cp-751-871-and-erlotinib-in-refractory-lung-cancer-53454https://curecurrent.com/trials/64cuatsm-and-hypoxia-in-stage-iv-non-small-cell-lung-cancer-with-carboplatin-paclitaxel-and-bevacizumab-53455https://curecurrent.com/trials/study-to-assess-safety-tolerability-and-pk-of-azd1480-in-patients-with-solid-tumours-53456https://curecurrent.com/trials/ro-50-3821-in-treating-anemia-in-patients-receiving-antineoplastic-therapy-for-stage-iiib-or-stage-iv-non-small-cell-lun-53457https://curecurrent.com/trials/preconditioning-chemotherapy-combination-with-cytokine-induced-killer-cell-cik-immunotherapy-53458https://curecurrent.com/trials/cci-779-in-treating-patients-with-stage-iiib-with-pleural-effusion-or-stage-iv-non-small-cell-lung-cancer-53459https://curecurrent.com/trials/study-of-combination-therapy-of-carboplatin-gemcitabine-plus-bevacizumab-beyond-progression-in-patients-with-locally-adv-53460https://curecurrent.com/trials/evaluation-of-carboplatin-plus-gemcitabine-followed-by-concomitant-chemoradiation-for-non-resectable-stage-iii-nsclc-53461https://curecurrent.com/trials/temsirolimus-and-radiation-for-non-small-cell-lung-cancer-53462https://curecurrent.com/trials/temozolomide-in-treating-patients-with-relapsed-or-progressive-small-cell-lung-cancer-53463https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-53464https://curecurrent.com/trials/chemotherapy-amifostine-and-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-53465https://curecurrent.com/trials/adoptive-immunotherapy-aldesleukin-and-zoledronate-in-treating-patients-with-stage-iv-kidney-cancer-and-lung-metastases-53466https://curecurrent.com/trials/combination-chemotherapy-and-tamoxifen-in-treating-patients-with-solid-tumors-53467https://curecurrent.com/trials/dx-8951f-in-treating-previously-untreated-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53468https://curecurrent.com/trials/concurrent-pemetrexed-cisplatin-and-radiation-therapy-in-patients-with-stage-iiia-b-non-small-cell-lung-cancer-53469https://curecurrent.com/trials/a-study-of-pc-sequential-pemetrexed-single-drug-maintenance-treatment-for-nsclc-and-related-predictive-biomarkers-53470https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-leptomeningeal-cancer-53471https://curecurrent.com/trials/vegfrs-predict-bevacizumab-benefit-in-advanced-non-small-cell-lung-cancer-53472https://curecurrent.com/trials/surgery-with-or-without-chemotherapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-53473https://curecurrent.com/trials/evaluation-of-the-persistence-of-the-complete-molecular-remission-after-stopping-imatinib-chronic-myeloid-leukemia-53474https://curecurrent.com/trials/veliparib-cisplatin-and-gemcitabine-hydrochloride-in-treating-patients-with-advanced-biliary-pancreatic-urothelial-or-no-53475https://curecurrent.com/trials/p16-methylation-for-smoking-cessation-53476https://curecurrent.com/trials/cisplatin-and-docetaxel-with-or-without-radiation-therapy-in-treating-patients-who-are-undergoing-surgery-for-newly-diag-53477https://curecurrent.com/trials/enoxaparin-low-molecular-weight-heparin-lmwh-in-advanced-non-small-cell-lung-cancer-effect-on-survival-and-symptom-contr-53478https://curecurrent.com/trials/video-assisted-surgery-or-talc-pleurodesis-in-treating-patients-with-malignant-mesothelioma-53479https://curecurrent.com/trials/to-evaluate-the-impact-of-pet-ct-on-radiation-treatment-planning-in-relation-to-changes-in-gtv-in-stage-3-nsclc-53480https://curecurrent.com/trials/first-line-study-of-tamibarotene-in-combination-for-advanced-non-small-cell-lung-cancer-53481https://curecurrent.com/trials/combination-chemotherapy-as-induction-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53482https://curecurrent.com/trials/ins316-in-diagnosing-lung-cancer-in-patients-with-untreated-lung-cancer-53483https://curecurrent.com/trials/alanosine-in-treating-patients-with-cancer-53484https://curecurrent.com/trials/tlk286-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53485https://curecurrent.com/trials/induction-erlotinib-therapy-in-stage-iii-a-n2-non-small-cell-lung-cancer-nsclc-53486https://curecurrent.com/trials/dual-pet-ct-imaging-in-lung-cancer-53487https://curecurrent.com/trials/bortezomib-in-treating-patients-with-recurrent-or-refractory-extensive-stage-small-cell-lung-cancer-previously-treated-w-53488https://curecurrent.com/trials/phenylbutyrate-plus-azacitidine-in-treating-patients-with-acute-myeloid-leukemia-myelodysplasia-non-hodgkin-s-lymphoma-m-53489https://curecurrent.com/trials/combination-chemotherapy-with-or-without-tirapazamine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lu-53490https://curecurrent.com/trials/a-study-of-the-effect-of-r1507-in-combination-with-tarceva-erlotinib-on-progression-free-survival-in-patients-with-stage-53491https://curecurrent.com/trials/a-study-with-tarceva-and-chemotherapy-vs-chemotherapy-alone-in-patients-with-advanced-lung-cancer-53492https://curecurrent.com/trials/trastuzumab-plus-chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53493https://curecurrent.com/trials/vaccine-therapy-plus-biological-therapy-in-treating-adults-with-metastatic-solid-tumors-53494https://curecurrent.com/trials/vaccine-therapy-chemotherapy-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-c-53495https://curecurrent.com/trials/phase-i-study-of-vorinostat-and-sorafenib-in-advanced-cancer-53496https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53497https://curecurrent.com/trials/study-of-pazopanib-and-pemetrexed-in-advanced-non-small-cell-lung-cancer-53498https://curecurrent.com/trials/sunitinib-as-a-second-line-treatment-for-patients-with-recurrent-small-cell-lung-cancer-53499https://curecurrent.com/trials/inhaled-doxorubicin-in-treating-patients-with-primary-lung-cancer-or-lung-metastases-53500https://curecurrent.com/trials/irinotecan-cisplatin-plus-simvastatin-in-extensive-disease-small-cell-lung-cancer-ed-sclc-53501https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53502https://curecurrent.com/trials/vaccine-therapy-plus-qs21-in-treating-patients-with-small-cell-lung-cancer-that-has-responded-to-initial-therapy-53503https://curecurrent.com/trials/vaccine-therapy-and-sargramostim-in-treating-patients-with-non-small-cell-lung-cancer-53504https://curecurrent.com/trials/a-safety-and-tolerability-study-of-pci-24781-in-subjects-with-cancer-53505https://curecurrent.com/trials/10-propargyl-10-deazaaminopterin-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53506https://curecurrent.com/trials/acupuncture-research-on-lung-cancer-patients-with-cancer-related-fatigue-crf-53507https://curecurrent.com/trials/cisplatin-with-or-without-pemetrexed-disodium-in-treating-patients-with-malignant-mesothelioma-of-the-pleura-that-cannot-53508https://curecurrent.com/trials/a-clinical-study-of-liposomal-doxorubicin-combined-with-ifosfamide-second-line-treatment-in-small-cell-lung-cancer-53509https://curecurrent.com/trials/thalidomide-in-treating-patients-with-metastatic-neuroendocrine-tumors-53510https://curecurrent.com/trials/inoperable-non-squamous-nsclc-stage-iii-iv-a-randomised-phase-ii-study-with-bevacizumab-plus-erlotinib-or-gemcitabine-ci-53511https://curecurrent.com/trials/neoadjuvant-chemotherapy-of-nanoparticle-albumin-bound-paclitaxel-carboplatin-vs-paclitaxel-carboplatin-in-stage-b-and-i-53512https://curecurrent.com/trials/erlotinib-and-celecoxib-in-treating-patients-with-stage-iiib-or-stage-iv-recurrent-non-small-cell-lung-cancer-53513https://curecurrent.com/trials/erlotinib-in-treating-patients-with-stage-i-iiia-non-small-cell-lung-cancer-undergoing-surgical-resection-53514https://curecurrent.com/trials/sorafenib-tosylate-in-treating-patients-with-malignant-mesothelioma-53515https://curecurrent.com/trials/epothilone-d-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-that-has-not-responded-to-plati-53516https://curecurrent.com/trials/combination-chemotherapy-radiation-therapy-and-gefitinib-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53517https://curecurrent.com/trials/identifying-unique-scent-signature-of-lung-cancer-through-body-odor-53518https://curecurrent.com/trials/romidepsin-in-treating-patients-with-locally-advanced-or-metastatic-neuroendocrine-tumors-53519https://curecurrent.com/trials/tipifarnib-gemcitabine-and-cisplatin-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-53520https://curecurrent.com/trials/suramin-paclitaxel-and-carboplatin-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53521https://curecurrent.com/trials/chemotherapy-radiation-therapy-and-surgery-in-treating-patients-with-stage-iiia-non-small-cell-lung-cancer-53522https://curecurrent.com/trials/suramin-and-either-docetaxel-or-gemcitabine-in-treating-patients-with-stage-iiib-or-stage-iv-platinum-refractory-non-sma-53523https://curecurrent.com/trials/docetaxel-with-either-cetuximab-or-bortezomib-as-first-line-therapy-in-treating-patients-with-stage-iii-or-stage-iv-non-53524https://curecurrent.com/trials/characteristics-of-mediastinal-lymph-node-with-false-positive-fdg-pet-ct-results-in-lung-cancer-staging-relation-with-tb-53525https://curecurrent.com/trials/a-study-of-bms-833923-with-carboplatin-and-etoposide-followed-by-bms-833923-alone-in-subjects-with-extensive-stage-small-53526https://curecurrent.com/trials/su5416-in-treating-patients-with-malignant-mesothelioma-53527https://curecurrent.com/trials/amrubicin-and-irinotecan-in-treating-patients-with-recurrent-or-relapsed-extensive-stage-small-cell-lung-cancer-53528https://curecurrent.com/trials/irinotecan-and-carboplatin-in-treating-patients-with-newly-diagnosed-extensive-stage-small-cell-lung-cancer-53529https://curecurrent.com/trials/efficacy-of-erlotinib-in-neoadjuvant-setting-in-patients-with-stage-iiia-n2-positive-non-small-cell-lung-cancer-53530https://curecurrent.com/trials/early-versus-late-concurrent-chemoradiation-for-limited-stage-small-cell-lung-cancer-53531https://curecurrent.com/trials/combination-anticancer-therapy-of-paclitaxel-and-everolimus-for-relapsed-or-refractory-small-cell-lung-cancer-53532https://curecurrent.com/trials/study-of-oral-vorinostat-in-combination-with-topotecan-in-patients-with-chemosensitive-recurrent-sclc-53533https://curecurrent.com/trials/trastuzumab-therapy-in-non-small-cell-lung-cancer-patients-53534https://curecurrent.com/trials/vaccine-therapy-tretinoin-and-cyclophosphamide-in-treating-patients-with-metastatic-lung-cancer-53535https://curecurrent.com/trials/phase-ii-study-of-dovitinib-for-fgfr1-amplified-squamous-non-small-cell-lung-cancer-53536https://curecurrent.com/trials/celecoxib-in-treating-patients-with-stage-i-stage-ii-or-stage-iiia-non-small-cell-lung-cancer-53537https://curecurrent.com/trials/a-study-of-the-combination-of-erlotinib-and-pertuzumab-in-patients-with-relapsed-non-small-cell-lung-cancer-53538https://curecurrent.com/trials/amifostine-chemotherapy-and-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-53539https://curecurrent.com/trials/fluorouracil-plus-interferon-alfa-in-treating-patients-with-advanced-metastatic-carcinoid-tumors-53540https://curecurrent.com/trials/3-ap-and-gemcitabine-as-second-line-therapy-in-treating-patients-with-stage-iii-or-stage-iv-recurrent-non-small-cell-lun-53541https://curecurrent.com/trials/liverpool-lung-project-risk-factors-and-genetic-markers-in-healthy-participants-and-patients-with-lung-cancer-53542https://curecurrent.com/trials/computer-assisted-scheduling-of-nicotine-inhaler-use-in-participants-who-plan-to-stop-smoking-53543https://curecurrent.com/trials/evaluation-of-efficacy-safety-and-tolerability-of-targretin-capsules-in-patients-with-advanced-or-metastatic-non-small-c-53544https://curecurrent.com/trials/gefitinib-in-treating-patients-with-previously-untreated-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53545https://curecurrent.com/trials/computer-assisted-volumetric-analysis-of-ct-identified-metastatic-pulmonary-or-hepatic-lesions-53546https://curecurrent.com/trials/chemotherapy-and-radiation-therapy-with-or-without-efaproxiral-in-treating-patients-with-stage-iii-non-small-cell-lung-c-53547https://curecurrent.com/trials/sequential-use-of-low-dose-sunitinib-with-chemotherapy-in-advanced-nsclc-after-failure-of-conventional-regimen-53548https://curecurrent.com/trials/a-randomized-study-to-evaluate-the-effect-of-two-different-doses-of-enoxaparin-sodium-in-combination-with-standard-chemo-53549https://curecurrent.com/trials/early-detection-of-lung-tumors-by-sniffer-dogs-evaluation-of-sensitivity-and-specificity-53550https://curecurrent.com/trials/lomustine-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-53551https://curecurrent.com/trials/imatinib-mesylate-and-bevacizumab-after-first-line-chemotherapy-and-bevacizumab-in-treating-patients-with-stage-iiib-or-53552https://curecurrent.com/trials/paclitaxel-plus-radiation-therapy-in-treating-patients-with-untreated-stage-iii-non-small-cell-lung-cancer-53553https://curecurrent.com/trials/dose-defining-study-for-mk-2206-combined-with-gefitinib-in-non-small-cell-lung-cancer-nsclc-53554https://curecurrent.com/trials/depression-screening-in-patients-with-lung-cancer-53555https://curecurrent.com/trials/study-of-lung-function-in-children-who-have-undergone-bone-marrow-transplantation-53556https://curecurrent.com/trials/imatinib-mesylate-after-irinotecan-and-cisplatin-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53557https://curecurrent.com/trials/gefitinib-and-celecoxib-in-treating-patients-with-refractory-non-small-cell-lung-cancer-53558https://curecurrent.com/trials/pyrazoloacridine-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53559https://curecurrent.com/trials/celecoxib-and-docetaxel-in-treating-patients-with-non-small-cell-lung-cancer-53560https://curecurrent.com/trials/zileuton-in-preventing-lung-cancer-in-patients-with-bronchial-dysplasia-53561https://curecurrent.com/trials/study-of-carboplatin-paclitaxel-in-combination-with-abt-869-in-subjects-with-advanced-or-metastatic-non-small-cell-lung-53562https://curecurrent.com/trials/celecoxib-and-docetaxel-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53563https://curecurrent.com/trials/oral-vinorelbine-as-induction-chemotherapy-followed-concomitant-chemoradiotherapy-53564https://curecurrent.com/trials/empyema-following-pneumonectomy-for-non-small-cell-lung-cancer-nsclc-53565https://curecurrent.com/trials/analysis-of-the-incidence-of-expression-of-tumor-antigens-in-pathologically-proven-stage-i-ii-and-iii-non-small-cell-lun-53566https://curecurrent.com/trials/alimta-versus-its-combination-with-carboplatin-in-advanced-non-small-cell-lung-cancer-in-patients-performance-status-2-53567https://curecurrent.com/trials/combination-chemotherapy-plus-peripheral-stem-cell-transplantation-in-treating-patients-with-metastatic-cancer-53568https://curecurrent.com/trials/cisplatin-interferon-alfa-surgery-and-radiation-therapy-in-treating-patients-with-malignant-pleural-mesothelioma-53569https://curecurrent.com/trials/paclitaxel-and-cisplatin-plus-radiation-therapy-followed-by-filgrastim-in-treating-patients-with-recurrent-head-and-neck-53570https://curecurrent.com/trials/a-registry-study-on-shenqifuzheng-a-chinese-medicine-injection-used-in-hospitals-in-china-53571https://curecurrent.com/trials/gefitinib-and-radiation-therapy-in-treating-patients-with-inoperable-stage-i-or-stage-ii-non-small-cell-lung-cancer-53572https://curecurrent.com/trials/active-symptom-control-alone-or-in-combination-with-oral-topotecan-in-patients-with-relapsed-resistant-small-cell-lung-c-53573https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-small-cell-lung-cancer-53574https://curecurrent.com/trials/lung-cancer-vaccine-plus-oral-dietary-supplement-53575https://curecurrent.com/trials/study-of-cp-751-871-in-combination-with-carboplatin-and-paclitaxel-in-advanced-lung-cancer-53576https://curecurrent.com/trials/safety-study-of-xl147-sar245408-in-combination-with-paclitaxel-and-carboplatin-in-adults-with-solid-tumors-53577https://curecurrent.com/trials/paclitaxel-carboplatin-and-dimethylxanthenone-acetic-acid-in-treating-patients-with-extensive-stage-small-cell-lung-canc-53578https://curecurrent.com/trials/fast-track-diagnosis-for-lung-cancer-suspects-with-pet-ct-and-eus-53579https://curecurrent.com/trials/the-effect-of-post-thoracotomy-pulmonary-rehabilitation-on-quality-of-life-53580https://curecurrent.com/trials/study-of-abt-869-in-subjects-with-advanced-non-small-cell-lung-cancer-nsclc-53581https://curecurrent.com/trials/ultrafiltration-aquapheresis-in-patients-with-leukemia-and-severe-fluid-overload-53582https://curecurrent.com/trials/erlotinib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53583https://curecurrent.com/trials/phase-ii-evaluation-of-exhaled-nitric-oxide-no-53584https://curecurrent.com/trials/outcome-measures-in-infant-early-childhood-lung-disease-w-chest-ct-scanning-lung-function-testing-53585https://curecurrent.com/trials/combination-chemotherapy-compared-with-no-treatment-following-surgery-in-treating-patients-with-non-small-cell-lung-canc-53586https://curecurrent.com/trials/a-window-of-opportunity-trial-of-afatinib-in-early-stage-non-small-cell-lung-cancer-nsclc-53587https://curecurrent.com/trials/phase-2-study-comparing-99mtc-ec-dg-spect-ct-with-18f-fdg-pet-ct-in-patients-with-non-small-cell-lung-cancer-nsclc-53588https://curecurrent.com/trials/pharmacokinetic-and-radiation-dosimetry-study-evaluating-99m-tc-ec-dg-spect-ct-in-patients-with-non-small-cell-lung-canc-53589https://curecurrent.com/trials/study-of-cp-751-871-in-combination-with-cisplatin-and-gemcitabine-in-chemotherapy-na-ve-patients-with-advanced-non-small-53590https://curecurrent.com/trials/study-to-evaluate-the-clinical-benefit-response-in-cancer-patients-with-advanced-disease-with-amt2003-versus-placebo-53591https://curecurrent.com/trials/a-study-of-nk012-in-patients-with-relapsed-small-cell-lung-cancer-53592https://curecurrent.com/trials/observational-post-authorization-studies-carboplatin-paclitaxel-and-bevacizumab-53593https://curecurrent.com/trials/endostar-gt-in-pulmonary-metastases-of-soft-tissue-sarcoma-53594https://curecurrent.com/trials/study-of-anxiety-and-avoidance-of-others-in-patients-previously-treated-for-head-and-neck-cancer-53595https://curecurrent.com/trials/panitumumab-plus-pemetrexed-and-cisplatin-pemcisp-versus-pemcis-in-the-first-line-treatment-of-patients-with-non-small-c-53596https://curecurrent.com/trials/a-trial-to-evaluate-the-impact-of-lung-protective-intervention-in-patients-undergoing-esophageal-cancer-surgery-53597https://curecurrent.com/trials/vinflunine-in-the-treatment-of-patients-with-relapsed-extensive-small-cell-lung-cancer-53598https://curecurrent.com/trials/s0002-a-program-to-quit-smoking-with-or-without-bupropion-in-treating-patients-with-stage-i-or-ii-non-small-cell-lung-ca-53599https://curecurrent.com/trials/evaluation-of-the-importance-of-risk-factor-adjustment-for-assessing-the-relationship-between-voriconazole-utilization-a-53600https://curecurrent.com/trials/stereotactic-body-radio-therapy-sbrt-for-early-stage-non-small-cell-lung-cancer-nsclc-53601https://curecurrent.com/trials/flt3l-in-treating-patients-with-metastatic-colorectal-cancer-53602https://curecurrent.com/trials/oral-topotecan-versus-intravenous-docetaxel-in-pretreated-advanced-non-small-cell-lung-cancer-53603https://curecurrent.com/trials/effect-of-astragalus-based-formula-qingshu-yiqi-tang-on-modulating-immune-alterations-in-lung-cancer-patients-53604https://curecurrent.com/trials/gemcitabine-carboplatin-and-bortezomib-in-advanced-or-recurrent-non-small-cell-lung-cancer-53605https://curecurrent.com/trials/gefitinib-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53606https://curecurrent.com/trials/a-randomized-phase-2-study-of-erlotinib-arq-197-versus-erlotinib-placebo-in-previously-treated-patients-with-locally-adv-53607https://curecurrent.com/trials/s0341-erlotinib-in-treating-patients-with-advanced-primary-non-small-cell-lung-cancer-53608https://curecurrent.com/trials/cci-779-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53609https://curecurrent.com/trials/safety-evaluation-of-dexmedetomidine-for-ebus-tbna-53610https://curecurrent.com/trials/combination-chemotherapy-and-radiation-therapy-with-or-without-gefitinib-in-treating-patients-with-stage-iii-non-small-c-53611https://curecurrent.com/trials/a-phase-ii-trial-of-triapine-nsc-663249-in-combination-with-gemcitabine-as-second-line-treatment-of-non-small-cell-lung-53612https://curecurrent.com/trials/combination-chemotherapy-with-or-without-bevacizumab-in-treating-patients-with-advanced-metastatic-or-recurrent-non-smal-53613https://curecurrent.com/trials/study-of-gefitinib-retreatment-in-non-small-cell-lung-cancer-nsclc-53614https://curecurrent.com/trials/a-study-of-cisplatin-or-carboplatin-and-etoposide-with-or-without-figitumumab-cp-751-871-in-patients-with-extensive-stag-53615https://curecurrent.com/trials/a-clinical-study-testing-the-safety-and-efficacy-of-crizotinib-in-east-asian-patients-with-anaplastic-lymphoma-kinase-al-53616https://curecurrent.com/trials/a-retrospective-study-to-investigate-the-current-situation-of-biopsy-testing-in-swedish-inoperable-non-small-cell-lung-c-53617https://curecurrent.com/trials/the-value-of-radiotherapy-in-the-oligometastatic-non-squamous-non-small-cell-lung-cancer-with-clinical-benefits-from-erl-53618https://curecurrent.com/trials/s0027-vinorelbine-followed-by-docetaxel-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53619https://curecurrent.com/trials/s0022-combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-stage-iiib-non-small-cell-lung-cancer-53620https://curecurrent.com/trials/s0119-combination-chemotherapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53621https://curecurrent.com/trials/s9914-combination-chemotherapy-plus-filgrastim-in-untreated-extensive-stage-small-cell-lung-cancer-53622https://curecurrent.com/trials/individualized-therapy-based-of-tumoral-mrna-levels-of-ercc1-rrm1-and-brca1-in-advanced-non-small-cell-lung-cancer-53623https://curecurrent.com/trials/a-study-for-non-smoker-patients-with-nonsquamous-non-small-cell-lung-cancer-53624https://curecurrent.com/trials/cisplatin-and-gemcitabine-with-or-without-bevacizumab-in-egfr-wild-type-non-small-cell-lung-cancer-53625https://curecurrent.com/trials/arsenic-trioxide-in-treating-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-53626https://curecurrent.com/trials/combination-of-rad001-with-carboplatin-paclitaxel-and-bevacizumab-in-non-small-cell-lung-cancer-nsclc-patients-53627https://curecurrent.com/trials/multimedia-patient-education-53628https://curecurrent.com/trials/radiation-therapy-plus-topotecan-in-treating-patients-with-non-small-cell-lung-cancer-53629https://curecurrent.com/trials/bevacizumab-paclitaxel-and-carboplatin-before-surgery-in-treating-patients-with-stage-ib-stage-ii-or-stage-iiia-non-smal-53630https://curecurrent.com/trials/paclitaxel-and-oxaliplatin-in-treating-patients-with-recurrent-or-advanced-non-small-cell-lung-cancer-53631https://curecurrent.com/trials/bryostatin-1-plus-paclitaxel-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-cancer-53632https://curecurrent.com/trials/bcl-2-antisense-oligodeoxynucleotide-g3139-and-paclitaxel-in-treating-patients-with-recurrent-small-cell-lung-cancer-53633https://curecurrent.com/trials/fenretinide-in-treating-patients-with-recurrent-small-cell-lung-cancer-53634https://curecurrent.com/trials/topotecan-and-radiation-therapy-in-treating-patients-with-solid-tumors-or-lymphoma-53635https://curecurrent.com/trials/a-study-in-patients-with-non-small-cell-lung-cancer-testing-if-erlotinib-plus-su011248-sunitinib-is-better-than-erlotini-53636https://curecurrent.com/trials/induction-chemotherapy-using-paclitaxel-carboplatin-cpt-11-with-pegfilgrastim-53637https://curecurrent.com/trials/photodynamic-therapy-plus-brachytherapy-in-treating-patients-with-lung-cancer-53638https://curecurrent.com/trials/prediction-of-the-effectiveness-of-hypofractionated-radiation-therapy-in-early-stage-lung-cancer-by-bio-imaging-and-biom-53639https://curecurrent.com/trials/gemcitabine-plus-carboplatin-or-cisplatin-in-treating-patients-with-stage-iiib-stage-iv-or-recurrent-non-small-cell-lung-53640https://curecurrent.com/trials/erlotinib-and-radiation-therapy-plus-combination-chemotherapy-in-treating-patients-with-inoperable-stage-iii-non-small-c-53641https://curecurrent.com/trials/tracking-of-respiratory-induced-tumor-motion-using-implanted-fiducials-53642https://curecurrent.com/trials/optical-coherence-tomography-an-adjunct-to-flexible-bronchoscopy-in-the-diagnosis-of-lung-cancer-53643https://curecurrent.com/trials/topotecan-and-carboplatin-in-the-first-line-treatment-of-patients-with-extensive-stage-small-cell-lung-cancer-53644https://curecurrent.com/trials/a-phase-1-2-study-evaluating-abt-751-in-combination-with-alimta-in-advanced-non-small-cell-lung-cancer-53645https://curecurrent.com/trials/s9900-surgery-with-or-without-combination-chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-53646https://curecurrent.com/trials/dimesna-in-treating-patients-with-solid-tumors-who-are-undergoing-treatment-with-cisplatin-and-paclitaxel-53647https://curecurrent.com/trials/regimen-for-the-treatment-of-cachexia-in-subjects-with-nsclc-53648https://curecurrent.com/trials/randomised-study-comparing-three-chemotherapy-regimens-in-non-small-cell-lung-cancer-53649https://curecurrent.com/trials/first-line-gefitinib-by-fdg-pet-metabolic-response-53650https://curecurrent.com/trials/study-of-m2es-with-paclitaxel-carboplatin-tc-regimen-in-advanced-non-small-cell-lung-cancer-nsclc-53651https://curecurrent.com/trials/phase-ii-trial-of-erlotinib-and-concurrent-palliative-thoracic-radiation-therapy-for-non-small-cell-lung-cancer-pearl-53652https://curecurrent.com/trials/paclitaxel-carboplatin-pc-followed-by-gefitinib-versus-pc-in-advanced-non-small-cell-lung-cancer-53653https://curecurrent.com/trials/maintenance-zd1839-iressa-following-completion-of-front-line-platinum-based-double-chemotherapy-in-subjects-with-advance-53654https://curecurrent.com/trials/evaluation-of-egfr-tki-resistance-mechanism-using-plasma-dna-analysis-53655https://curecurrent.com/trials/natural-history-of-lung-nodules-seen-on-ct-scans-from-participants-at-high-risk-of-developing-lung-cancer-53656https://curecurrent.com/trials/combination-chemotherapy-plus-oblimersen-in-treating-patients-with-previously-untreated-extensive-stage-small-cell-lung-53657https://curecurrent.com/trials/multiple-respiration-correlated-cone-beam-computed-tomography-ct-scans-to-reduce-target-positioning-errors-in-radiothera-53658https://curecurrent.com/trials/autologous-sct-followed-by-dendritic-cell-p53-vaccination-in-patients-with-limited-stage-small-cell-lung-cancer-53659https://curecurrent.com/trials/erlotinib-in-treating-patients-with-malignant-mesothelioma-of-the-lung-53660https://curecurrent.com/trials/molecular-epidemiology-of-lung-adenocarcinoma-in-multi-ethnic-asian-phenotype-53661https://curecurrent.com/trials/gti-2040-and-docetaxel-in-treating-patients-with-recurrent-metastatic-or-unresectable-locally-advanced-non-small-cell-lu-53662https://curecurrent.com/trials/combination-chemotherapy-plus-radiation-therapy-with-or-without-ae-941-in-treating-patients-with-stage-iii-non-small-cel-53663https://curecurrent.com/trials/bortezomib-plus-gemcitabine-and-carboplatin-in-treating-patients-with-advanced-or-recurrent-non-small-cell-lung-cancer-53664https://curecurrent.com/trials/a-prospective-randomized-study-comparing-the-target-volume-for-limited-stage-small-cell-lung-cancer-53665https://curecurrent.com/trials/pet-scan-in-patients-with-lung-and-esophageal-cancers-that-may-be-removed-by-surgery-53666https://curecurrent.com/trials/follow-up-modalities-of-low-grade-precancerous-bronchial-lesions-53667https://curecurrent.com/trials/evaluation-of-preoperative-endobronchial-ultrasound-ebus-in-non-small-cell-lung-cancer-nsclc-53668https://curecurrent.com/trials/a-phase-ii-trial-of-genexol-pm-and-gemcitabine-in-patients-with-advanced-non-small-cell-lung-cancer-53669https://curecurrent.com/trials/gefitinib-in-treating-patients-with-malignant-mesothelioma-53670https://curecurrent.com/trials/radiation-therapy-bevacizumab-paclitaxel-and-carboplatin-in-treating-patients-with-unresectable-stage-iiib-or-stage-iv-n-53671https://curecurrent.com/trials/a-study-of-continuous-endostar-intravenous-infusion-combined-with-pemetrexed-and-carboplatin-in-advanced-non-small-cell-53672https://curecurrent.com/trials/trastuzumab-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-that-overexpresses-her2-53673https://curecurrent.com/trials/ef5-and-motexafin-lutetium-in-detecting-tumor-cells-in-patients-with-abdominal-or-non-small-cell-lung-cancer-53674https://curecurrent.com/trials/ef5-in-detecting-oxygen-level-and-blood-vessels-in-tumor-cells-of-patients-undergoing-photodynamic-therapy-for-intraperi-53675https://curecurrent.com/trials/bortezomib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53676https://curecurrent.com/trials/pet-imaging-in-potentially-surgically-resectable-non-small-cell-lung-cancers-53677https://curecurrent.com/trials/comparison-of-sequencing-and-pna-clamping-of-egfr-gene-in-patients-with-non-small-cell-type-lung-cancer-53678https://curecurrent.com/trials/carboplatin-and-etoposide-with-or-without-oblimersen-sodium-in-treating-patients-with-extensive-stage-small-cell-lung-ca-53679https://curecurrent.com/trials/gefitinib-in-treating-patients-with-metastatic-or-unresectable-head-and-neck-cancer-or-non-small-cell-lung-cancer-53680https://curecurrent.com/trials/randomized-multi-center-open-label-study-of-pr104-versus-pr104-docetaxel-in-non-small-cell-lung-cancer-nsclc-53681https://curecurrent.com/trials/feasibility-of-a-short-home-based-rehabilitation-program-for-cancer-patients-waiting-for-lung-resection-surgery-53682https://curecurrent.com/trials/erlotinib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-ovarian-cancer-or-squamous-cell-carcinoma-of-the-53683https://curecurrent.com/trials/a-phase-i-study-of-azd1480-in-patients-with-advanced-solid-malignancies-and-advanced-hepatocellular-carcinoma-in-the-esc-53684https://curecurrent.com/trials/monoclonal-antibody-abx-egf-in-treating-patients-with-renal-kidney-prostate-pancreatic-non-small-cell-lung-colon-or-rect-53685https://curecurrent.com/trials/s0429-docetaxel-cetuximab-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53686https://curecurrent.com/trials/iressa-expanded-access-program-eap-53687https://curecurrent.com/trials/trial-of-ag-013736-cisplatin-and-gemcitabine-for-patients-with-squamous-non-small-cell-lung-cancer-53688https://curecurrent.com/trials/pilot-study-of-zoledronic-acid-in-combination-with-first-line-chemotherapy-in-aged-patients-with-lung-cancer-53689https://curecurrent.com/trials/docetaxel-and-gemcitabine-with-filgrastim-sd-01-support-in-patients-with-advanced-non-small-cell-lung-carcinoma-53690https://curecurrent.com/trials/gefitinib-or-docetaxel-as-second-line-therapy-for-wild-type-epidermal-growth-factor-receptor-egfr-nsclc-53691https://curecurrent.com/trials/pulmonary-function-in-patients-with-hodgkin-s-disease-receiving-bleomycin-based-chemotherapy-53692https://curecurrent.com/trials/vinorelbine-and-ifosfamide-as-third-line-treatment-for-refractory-small-cell-lung-cancer-53693https://curecurrent.com/trials/phase-i-safety-and-tolerability-study-of-cediranib-recentin-azd2171-in-combination-with-chemo-in-first-line-lung-cancer-53694https://curecurrent.com/trials/vinorelbine-ifosfamide-versus-gefitinib-for-egfr-gene-mutation-negative-non-small-cell-lung-cancer-patients-53695https://curecurrent.com/trials/epidemiological-study-to-describe-non-small-cell-lung-carcinoma-nsclc-clinical-management-patterns-in-mena-lung-epiclin-53696https://curecurrent.com/trials/intratumoral-cancer-chemotherapy-through-a-flexible-bronchoscope-as-an-adjunct-to-brachytherapy-53697https://curecurrent.com/trials/cetuximab-and-combination-chemotherapy-as-first-line-therapy-in-treating-patients-with-colorectal-cancer-that-has-spread-53698https://curecurrent.com/trials/melatonin-versus-placebo-and-the-effect-on-appetite-in-advanced-cancer-patients-53699https://curecurrent.com/trials/study-of-ave0005-vegf-trap-in-locally-advanced-or-metastatic-platinum-and-erlotinib-resistant-non-small-cell-lung-adenoc-53700https://curecurrent.com/trials/pr104-in-treating-patients-with-previously-untreated-or-relapsed-small-cell-lung-cancer-53701https://curecurrent.com/trials/phase-i-ii-safety-study-of-ipi-504-in-relapsed-refractory-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-nsclc-53702https://curecurrent.com/trials/study-of-chemotherapy-sequenced-by-or-combined-with-egfr-tkis-for-nsclc-patients-failed-to-egfr-tkis-therapy-53703https://curecurrent.com/trials/higher-dose-weekly-topotecan-in-the-treatment-of-patients-with-extensive-stage-small-cell-lung-cancer-53704https://curecurrent.com/trials/study-of-pemetrexed-versus-gefitinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-who-have-53705https://curecurrent.com/trials/feasibility-of-using-real-time-cine-mri-for-treating-moving-deforming-tumors-53706https://curecurrent.com/trials/trial-to-evaluate-radiotherapy-with-or-without-cbdca-in-elderly-patients-with-non-small-cell-lung-cancer-jcog0301-53707https://curecurrent.com/trials/respiratory-muscle-function-changes-and-effects-of-chest-physiotherapy-education-interventionin-advanced-lung-cancer-53708https://curecurrent.com/trials/celecoxib-as-adjuvant-biologic-therapy-in-patients-with-head-and-neck-and-lung-cancer-53709https://curecurrent.com/trials/docetaxel-plus-cisplatin-followed-by-gemcitabine-versus-gemcitabine-plus-cisplatin-followed-by-docetaxel-for-non-small-c-53710https://curecurrent.com/trials/immuno-augmentation-with-gm-csf-of-pneumococcal-vaccine-in-chronic-lymphocytic-leukemia-patients-53711https://curecurrent.com/trials/cisplatinum-pemetrexed-versus-split-dose-cisplatinum-pemetrexed-in-nsclc-53712https://curecurrent.com/trials/zometa-adjuvant-treatment-of-malignant-pleural-effusion-due-to-non-small-cell-lung-cancer-53713https://curecurrent.com/trials/evaluating-the-pulmonary-nodule-with-imaging-and-biomarkers-53714https://curecurrent.com/trials/escitalopram-in-treating-depression-in-patients-with-advanced-lung-or-gastrointestinal-cancer-53715https://curecurrent.com/trials/endobronchial-ultrasound-transbronchial-needle-aspiration-using-needle-suction-versus-no-suction-53716https://curecurrent.com/trials/a-study-of-pemetrexed-plus-carboplatin-or-pemetrexed-plus-cisplatin-with-radiation-therapy-followed-by-pemetrexed-in-pat-53717https://curecurrent.com/trials/e-ab-sensor-based-real-time-detection-of-mutant-egfr-in-clinical-specimens-from-patients-of-non-small-cell-lung-cancer-53718https://curecurrent.com/trials/photodynamic-therapy-pdt-in-lung-cancer-53719https://curecurrent.com/trials/gemcitabine-docetaxel-and-cetuximab-in-patients-with-unresectable-advanced-non-small-cell-lung-cancer-53720https://curecurrent.com/trials/a-study-of-the-igf-1r-inhibitor-axl1717-in-combination-with-gemcitabine-hcl-and-carboplatin-to-treat-non-small-cell-lung-53721https://curecurrent.com/trials/r115777-in-treating-patients-with-relapsed-small-cell-lung-cancer-53722https://curecurrent.com/trials/a-study-of-pegylated-rhg-csf-as-support-to-advanced-non-small-cell-lung-cancer-nsclc-patients-receiving-chemotherapy-rec-53723https://curecurrent.com/trials/observational-study-to-characterize-the-incidence-of-egfr-mutation-positive-and-advanced-nsclc-patients-53724https://curecurrent.com/trials/virtual-bronchoscopy-transbronchial-needle-aspiration-tbna-a-proof-of-concept-study-53725https://curecurrent.com/trials/s0229-pulmonary-rehabilitation-education-w-wo-exercise-training-in-improving-physical-function-in-patients-who-are-under-53726https://curecurrent.com/trials/a-study-of-hgs1036-in-combination-with-chemotherapy-in-subjects-with-advanced-solid-malignancies-53727https://curecurrent.com/trials/early-detection-of-lung-cancer-and-mesothelioma-in-workers-exposed-to-asbestos-53728https://curecurrent.com/trials/endobronchial-ultrasound-transbronchial-needle-aspiration-ebus-tbna-versus-mediastinoscopy-for-mediastinal-lymph-node-st-53729https://curecurrent.com/trials/s0342-paclitaxel-carboplatin-and-cetuximab-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53730https://curecurrent.com/trials/s0526-pemetrexed-disodium-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-53731https://curecurrent.com/trials/neoadjuvant-iressa-as-single-agent-preoptherapy-for-nsclc-with-molecular-correlates-53732https://curecurrent.com/trials/c11-erlotinib-pet-ct-as-a-tool-for-identification-and-characterization-of-tumor-with-high-expression-of-epidermal-growth-53733https://curecurrent.com/trials/combined-modality-therapy-with-growth-factor-support-in-locally-advanced-non-small-cell-lung-cancer-nsclc-53734https://curecurrent.com/trials/study-of-erlotinib-with-docetaxel-in-selected-non-small-cell-lung-cancer-patients-in-first-line-treatment-53735https://curecurrent.com/trials/targeting-er-golgi-homeostasis-in-an-advantageous-therapeutic-strategy-in-lung-cancer-53736https://curecurrent.com/trials/131i-l19sip-radioimmunotherapy-combined-with-radiochemotherapy-in-patients-with-locally-advanced-non-small-cell-lung-can-53737https://curecurrent.com/trials/respiratory-tumor-and-normal-tissue-motion-53738https://curecurrent.com/trials/cpt-11-cisplatin-and-celecoxib-with-radiation-therapy-for-patients-with-unresectable-non-small-cell-lung-cancer-nsclc-53739https://curecurrent.com/trials/study-of-oral-vinorelbine-and-erlotinib-in-non-small-cell-lung-cancer-53740https://curecurrent.com/trials/once-daily-accelerated-fractionation-with-concomitant-boost-to-the-gross-tumor-volume-compared-with-twice-daily-hyperfra-53741https://curecurrent.com/trials/combined-application-of-ebus-and-eus-in-lung-cancer-53742https://curecurrent.com/trials/a-pilot-study-of-pet-ct-in-the-assessment-of-pulmonary-nodules-in-children-with-malignant-solid-tumors-53743https://curecurrent.com/trials/curative-effect-study-of-endostatin-combined-with-chemoradiotherapy-to-non-small-cell-lung-cancer-53744https://curecurrent.com/trials/docetaxel-or-pemetrexed-with-or-without-cetuximab-in-patients-with-recurrent-or-progressive-non-small-cell-lung-cancer-53745https://curecurrent.com/trials/tariquidar-and-docetaxel-to-treat-patients-with-lung-ovarian-renal-and-cervical-cancer-53746https://curecurrent.com/trials/swog-9416-chemotherapy-radiation-therapy-and-surgery-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53747https://curecurrent.com/trials/s9806-combination-chemotherapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53748https://curecurrent.com/trials/s9810-gemcitabine-plus-cisplatin-in-treating-patients-with-malignant-mesothelioma-of-the-pleura-that-cannot-be-removed-b-53749https://curecurrent.com/trials/gefitinib-and-sirolimus-in-treating-patients-with-recurrent-or-refractory-stage-iiib-or-stage-iv-non-small-cell-lung-can-53750https://curecurrent.com/trials/s0004-combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-53751https://curecurrent.com/trials/stereotactic-radiosurgery-and-erlotinib-in-treating-patients-with-non-small-cell-lung-cancer-and-brain-metastases-53752https://curecurrent.com/trials/de-novo-resistance-to-epidermal-growth-factor-receptor-tyrosine-kinase-inhibitors-53753https://curecurrent.com/trials/seline-second-line-iressa-phase-iv-study-in-nsclc-patients-53754https://curecurrent.com/trials/carotene-and-retinol-efficacy-trial-53755https://curecurrent.com/trials/fluorine-f18-ef5-and-fludeoxyglucose-f18-positron-emission-tomography-in-assessing-hypoxia-and-glycolysis-in-patients-wi-53756https://curecurrent.com/trials/clinical-evaluation-of-the-new-hypoxia-imaging-agent-hx4-53757https://curecurrent.com/trials/radiation-therapy-to-prevent-brain-metastases-in-patients-with-previously-treated-extensive-stage-small-cell-lung-cancer-53758https://curecurrent.com/trials/acridine-carboxamide-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53759https://curecurrent.com/trials/glufosfamide-with-of-without-hydration-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53760https://curecurrent.com/trials/nitrocamptothecin-in-treating-patients-with-advanced-small-cell-lung-cancer-53761https://curecurrent.com/trials/high-dose-3-dimensional-conformal-radiation-therapy-in-treating-patients-with-inoperable-stage-i-stage-ii-or-stage-iiia-53762https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-metastatic-ovarian-cancer-or-non-small-cell-lung-cancer-53763https://curecurrent.com/trials/phase-ii-trial-of-double-dose-of-icotinib-in-treating-brain-metastases-from-non-small-cell-lung-cancer-53764https://curecurrent.com/trials/effect-of-endostar-combined-with-chemotherapy-and-radiotherapy-on-blood-vessels-and-microenvironment-of-tumor-for-non-sm-53765https://curecurrent.com/trials/mr-guided-focused-ultrasound-surgery-of-metastatic-bone-tumors-53766https://curecurrent.com/trials/observational-study-on-the-management-of-patients-with-non-small-cell-lung-cancer-adenocarcinoma-53767https://curecurrent.com/trials/cs-1008-with-carboplatin-paclitaxel-in-chemotherapy-na-ve-subjects-with-metastatic-or-unresectable-non-small-cell-lung-c-53768https://curecurrent.com/trials/ph-ii-concurrent-chemo-t-docetaxel-carboplatin-radio-therapy-consolidation-t-locally-adv-inoperable-non-small-cell-lung-53769https://curecurrent.com/trials/cetuximab-as-therapy-for-recurrent-non-small-cell-lung-cancer-patients-who-have-received-prior-therapy-53770https://curecurrent.com/trials/cisplatin-etoposide-and-cyclophosphamide-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53771https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-lung-cancer-53772https://curecurrent.com/trials/integration-of-neutron-therapy-in-the-treatment-plan-for-stage-iii-non-small-cell-lung-cancer-nsclc-53773https://curecurrent.com/trials/safety-and-efficacy-of-talactoferrin-in-previously-treated-patients-with-non-small-cell-lung-cancer-53774https://curecurrent.com/trials/satraplatin-for-locally-advanced-non-small-cell-lung-cancer-with-simultaneous-radiotherapy-53775https://curecurrent.com/trials/efficacy-and-safety-of-obatoclax-mesylate-in-combination-with-carboplatin-and-etoposide-compared-with-carboplatin-and-et-53776https://curecurrent.com/trials/tumor-markers-in-lung-cancer-53777https://curecurrent.com/trials/tumor-markers-in-lung-cancer-dcamlk-1lk-1-53778https://curecurrent.com/trials/gemcitabine-with-or-without-ci-994-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53779https://curecurrent.com/trials/erlotinib-tarceva-as-a-single-agent-or-intercalated-with-combination-chemotherapy-in-patients-with-egfr-positive-nsclc-53780https://curecurrent.com/trials/a-phase-2-study-in-patients-with-advanced-non-small-cell-lung-cancer-using-new-agents-with-and-without-docetaxel-53781https://curecurrent.com/trials/erlotinib-vs-standard-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-and-eastern-cooperative-on-53782https://curecurrent.com/trials/prinomastat-and-combination-chemotherapy-in-treating-patients-with-metastatic-or-recurrent-non-small-cell-lung-cancer-53783https://curecurrent.com/trials/a-two-stage-phase-1-dose-escalation-pharmacokinetic-study-of-tarceva-in-patients-with-stage-iiib-iv-non-small-cell-lung-53784https://curecurrent.com/trials/evaluation-of-the-bio-seal-biopsy-track-plug-53785https://curecurrent.com/trials/study-of-gleevec-and-taxotere-in-recurrent-non-small-cell-lung-cancer-53786https://curecurrent.com/trials/a-study-of-mycobacterium-w-in-combination-with-paclitaxel-plus-cisplatin-in-advanced-non-small-cell-lung-cancer-53787https://curecurrent.com/trials/a-study-comparing-sequential-satraplatin-erlotinib-to-erlotinib-in-unresectable-stage-3-4-non-small-cell-lung-cancer-nsc-53788https://curecurrent.com/trials/the-anti-ctla-4-monoclonal-antibody-tremelimumab-in-malignant-mesothelioma-53789https://curecurrent.com/trials/aerosol-l9-nc-and-temozolomide-in-ewing-s-sarcoma-53790https://curecurrent.com/trials/longitudinal-study-of-multiple-symptoms-in-advanced-lung-cancer-53791https://curecurrent.com/trials/vibration-response-imaging-vri-in-lung-cancer-patients-53792https://curecurrent.com/trials/iressa-docetaxel-in-non-small-cell-lung-cancer-53793https://curecurrent.com/trials/study-about-preventive-treatment-of-folliculitis-induced-by-epidermal-growth-factor-receptor-inhibitors-53794https://curecurrent.com/trials/interactive-voice-response-system-ivrs-for-managing-symptoms-of-patients-following-thoracic-surgery-53795https://curecurrent.com/trials/interleukin-12-in-treating-patients-with-cancer-in-the-abdomen-53796https://curecurrent.com/trials/irinotecan-and-carboplatin-as-first-line-therapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-53797https://curecurrent.com/trials/cisplatin-and-pemetrexed-with-radiation-followed-by-lobectomy-53798https://curecurrent.com/trials/a-clinical-study-with-tremelimumab-as-monotherapy-in-malignant-mesothelioma-53799https://curecurrent.com/trials/s9714-paclitaxel-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53800https://curecurrent.com/trials/s0310-vaccine-therapy-in-treating-patients-with-stage-iiib-or-stage-iv-bronchoalveolar-lung-cancer-53801https://curecurrent.com/trials/s9712-radiation-therapy-and-combination-chemotherapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53802https://curecurrent.com/trials/assessment-of-symptom-related-cytokines-in-lung-and-gastrointestinal-gi-cancer-patients-53803https://curecurrent.com/trials/combination-chemotherapy-and-celecoxib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53804https://curecurrent.com/trials/pemetrexed-disodium-and-cisplatin-followed-by-surgery-and-radiation-therapy-in-treating-patients-with-malignant-pleural-53805https://curecurrent.com/trials/docetaxel-and-cisplatin-in-treating-patients-with-untreated-stage-iiia-non-small-cell-lung-cancer-53806https://curecurrent.com/trials/monoclonal-antibody-therapy-plus-bcg-in-treating-patients-with-limited-stage-small-cell-lung-cancer-53807https://curecurrent.com/trials/raltitrexed-in-treating-patients-with-malignant-mesothelioma-that-cannot-be-surgically-removed-53808https://curecurrent.com/trials/pemetrexed-disodium-and-cisplatin-before-or-after-surgery-in-treating-patients-with-stage-ib-or-stage-ii-non-small-cell-53809https://curecurrent.com/trials/cisplatin-with-or-without-raltitrexed-in-treating-patients-with-malignant-mesothelioma-of-the-pleura-53810https://curecurrent.com/trials/chemotherapy-plus-radiation-therapy-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-t-53811https://curecurrent.com/trials/safety-study-using-weekly-infusions-of-bb-10901-in-patients-with-small-cell-lung-cancer-53812https://curecurrent.com/trials/combination-chemotherapy-plus-radiation-therapy-followed-by-surgery-in-treating-patients-with-stage-iiib-non-small-cell-53813https://curecurrent.com/trials/pleural-ultrasonography-in-lung-cancer-53814https://curecurrent.com/trials/gefitinib-after-chemotherapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53815https://curecurrent.com/trials/gemcitabine-cisplatin-and-gefitinib-in-treating-patients-who-are-undergoing-surgery-for-stage-iii-non-small-cell-lung-ca-53816https://curecurrent.com/trials/miles-02-study-of-chemotherapy-treatment-and-toxicity-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-53817https://curecurrent.com/trials/evaluation-of-efficacy-safety-and-tolerability-of-targretin-capsules-in-patients-with-advanced-or-metastatic-non-small-c-53818https://curecurrent.com/trials/evaluation-of-cyberknife-precision-radiation-delivery-system-for-unresectable-malignant-lung-cancer-53819https://curecurrent.com/trials/isis-3521-in-treating-patients-with-advanced-unresectable-or-metastatic-non-small-cell-lung-cancer-or-unresectable-or-me-53820https://curecurrent.com/trials/surgery-with-or-without-combination-chemotherapy-in-treating-patients-with-lung-metastases-from-soft-tissue-sarcoma-53821https://curecurrent.com/trials/krn7000-in-treating-patients-with-solid-tumors-53822https://curecurrent.com/trials/radiation-therapy-chemotherapy-and-bevacizumab-in-treating-patients-with-recurrent-unresectable-or-stage-iii-or-stage-iv-53823https://curecurrent.com/trials/effects-of-humidified-ventilation-on-arterial-oxygenation-and-respiratory-mechanics-during-one-lung-ventilation-53824https://curecurrent.com/trials/study-of-relationship-between-ugt1a1-gene-polymorphism-and-toxicity-and-efficacy-of-irinotecan-in-small-cell-lung-cancer-53825https://curecurrent.com/trials/maintenance-therapy-with-autologous-cytokine-induced-killer-cells-for-nonsquamous-non-small-cell-lung-cancer-53826https://curecurrent.com/trials/maintenance-therapy-with-autologous-cytokine-induced-killer-cells-for-small-cell-lung-cancer-53827https://curecurrent.com/trials/chemotherapy-followed-by-surgery-or-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53828https://curecurrent.com/trials/temozolomide-in-patients-with-progressive-or-recurrent-non-small-cell-lung-cancer-53829https://curecurrent.com/trials/paclitaxel-in-treating-patients-with-lung-cancer-53830https://curecurrent.com/trials/observational-study-of-best-supportive-care-with-or-without-surgery-chemo-or-radiotherapy-in-pts-with-carcinoma-of-lung-53831https://curecurrent.com/trials/fludeoxyglucose-f-18-pet-ct-scans-in-predicting-therapy-response-in-patients-with-stage-iiia-non-small-cell-lung-cancer-53832https://curecurrent.com/trials/k-ras-oncogene-mutation-in-patients-with-advanced-non-small-cell-lung-cancer-associated-with-exposure-to-wood-smoke-and-53833https://curecurrent.com/trials/an-open-label-study-of-qd-oral-administration-of-tivozanib-av-951-in-subjects-with-non-small-cell-lung-cancer-nsclc-53834https://curecurrent.com/trials/clinical-trial-of-the-safety-and-effectiveness-of-chr-2797-with-erlotinib-in-patients-with-locally-advanced-or-metastati-53835https://curecurrent.com/trials/surgery-combined-with-rad-p53-gene-in-treatment-advanced-non-small-cell-carcinoma-53836https://curecurrent.com/trials/randomized-trial-of-docetaxel-and-gemcitabine-versus-gemcitabine-in-elderly-patients-with-nsclc-53837https://curecurrent.com/trials/enhancing-adherence-and-knowledge-of-erlotinib-in-patients-wtih-non-small-cell-lung-cancer-53838https://curecurrent.com/trials/enbrel-versus-placebo-with-radiation-therapy-to-combat-fatigue-and-cachexia-53839https://curecurrent.com/trials/anti-angiogenesis-agent-ag-013736-in-patients-with-advanced-non-small-cell-lung-cancer-53840https://curecurrent.com/trials/a-study-in-patients-who-will-undergo-surgical-removal-of-non-small-cell-lung-cancer-to-evaluate-molecular-changes-that-o-53841https://curecurrent.com/trials/sonography-after-thoracic-surgery-sats-53842https://curecurrent.com/trials/chest-computed-tomography-ct-screening-study-with-antibody-testing-53843https://curecurrent.com/trials/minimally-invasive-diagnosis-and-staging-of-lung-cancer-53844https://curecurrent.com/trials/intercalated-administration-of-pamcis-with-gefitinib-or-placebo-as-first-line-lung-adenocarcinoma-in-never-smokers-53845https://curecurrent.com/trials/a-study-of-thymidylate-synthase-expression-in-patients-with-non-small-cell-lung-cancer-53846https://curecurrent.com/trials/pilot-study-for-evaluating-the-role-of-f-18-flt-pet-ct-in-therapeutic-decision-making-in-non-small-cell-lung-cancer-53847https://curecurrent.com/trials/s0122-combination-chemotherapy-radiation-therapy-and-vaccine-therapy-in-limited-stage-small-cell-lung-cancer-53848https://curecurrent.com/trials/gene-expression-profiles-in-cns-metastatic-non-small-cell-lung-cancer-53849https://curecurrent.com/trials/pazopanib-as-pre-surgical-therapy-in-treatment-naive-subjects-with-non-small-cell-lung-cancer-53850https://curecurrent.com/trials/oltipraz-in-the-prevention-of-lung-cancer-in-people-who-smoke-53851https://curecurrent.com/trials/celecoxib-in-treating-patients-with-early-stage-head-and-neck-cancer-or-non-small-cell-lung-cancer-53852https://curecurrent.com/trials/adjuvant-bemiparin-in-small-cell-lung-carcinoma-abel-study-53853https://curecurrent.com/trials/randomized-study-of-cp-675-206-or-best-supportive-care-immediately-after-platinum-based-therapy-for-non-small-cell-lung-53854https://curecurrent.com/trials/iressa-as-second-line-therapy-in-advanced-nsclc-asia-53855https://curecurrent.com/trials/zd4054-zibotentan-phase-ii-non-small-cell-lung-cancer-study-53856https://curecurrent.com/trials/an-open-label-phase-ii-trial-of-zd1839-iressa-in-patients-with-malignant-mesothelioma-53857https://curecurrent.com/trials/combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-53858https://curecurrent.com/trials/carboplatin-plus-vinorelbine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-53859https://curecurrent.com/trials/gefitinib-as-first-line-therapy-followed-by-gemcitabine-and-cisplatin-in-treating-patients-with-stage-iii-or-stage-iv-no-53860https://curecurrent.com/trials/radiation-therapy-combined-with-either-gefitinib-or-temozolomide-in-pats-with-nsclc-and-brain-metastases-53861https://curecurrent.com/trials/carboplatin-paclitaxel-and-tlk286-telcyta-as-first-line-therapy-in-advanced-non-small-cell-lung-cancer-53862https://curecurrent.com/trials/a-double-blind-randomized-placebo-controlled-multicenter-phase-iii-study-of-tariquidar-paclitaxel-carboplatin-as-first-l-53863https://curecurrent.com/trials/a-double-blind-randomized-placebo-controlled-multicenter-phase-iii-study-of-tariquidar-vinorelbine-as-first-line-therapy-53864https://curecurrent.com/trials/calc-1-cetuximab-in-advanced-lung-cancer-study-of-2-methods-of-combining-cetuximab-and-gemcitabine-in-patients-with-adva-53865https://curecurrent.com/trials/soblidotin-in-treating-patients-with-progressive-locally-advanced-or-metastatic-non-small-cell-lung-cancer-53866https://curecurrent.com/trials/chemotherapy-combined-with-whole-body-hyperthermia-to-treat-stage-iiib-iv-non-small-cell-lung-cancer-53867https://curecurrent.com/trials/combination-chemotherapy-before-surgery-in-treating-patients-with-mesothelioma-of-the-lung-53868https://curecurrent.com/trials/a-phase-ii-study-of-eloxatin-and-alimta-in-combination-with-bevacizumab-in-advanced-non-squamous-nsclc-53869https://curecurrent.com/trials/a-phase-ii-single-arm-trial-of-single-agent-vinflunine-as-second-line-treatment-of-advanced-non-small-cell-lung-cancer-53870https://curecurrent.com/trials/a-phase-2-open-label-multicenter-study-of-the-garft-inhibitor-in-patients-with-metastatic-non-small-cell-lung-cancer-53871https://curecurrent.com/trials/case-analysis-on-real-life-incidence-of-photodynamic-therapy-pdt-safety-outcomes-53872https://curecurrent.com/trials/pemetrexed-with-or-without-carboplatin-for-elderly-non-squamous-non-small-cell-lung-cancer-53873https://curecurrent.com/trials/tachosil-versus-standard-surgical-treatment-for-air-leakage-in-pulmonary-lobectomy-tc-021-im-53874https://curecurrent.com/trials/an-observational-study-of-the-ethnic-impact-of-patients-undergoing-second-2nd-line-treatment-for-non-small-cell-lung-can-53875https://curecurrent.com/trials/bay-43-9006-sorafenib-to-treat-relapsed-non-small-cell-lung-cancer-53876https://curecurrent.com/trials/phase-ii-trial-of-dose-dense-paclitaxel-and-cisplatin-as-neo-adjuvant-chemotherapy-for-operable-stage-ii-and-iia-nsclc-53877https://curecurrent.com/trials/satraplatin-and-paclitaxel-in-patients-with-advanced-non-small-cell-lung-cancer-53878https://curecurrent.com/trials/a-phase-1b-study-with-volociximab-in-combination-with-carboplatin-paclitaxel-and-bevacizumab-in-first-line-advanced-non-53879https://curecurrent.com/trials/clinical-trial-of-a-therapeutic-vaccine-with-ny-eso-1-in-combination-with-the-adjuvant-monophosphoryl-lipid-a-mpla-53880https://curecurrent.com/trials/randomized-gefitinib-trial-53881https://curecurrent.com/trials/exercise-study-in-patients-with-lung-cancer-53882https://curecurrent.com/trials/study-of-the-telomerase-vaccine-gv1001-to-treat-patients-with-inoperable-stage-iii-non-small-cell-lung-cancer-53883https://curecurrent.com/trials/quality-of-life-comparison-in-advanced-non-squamous-non-small-cell-lung-cancer-53884https://curecurrent.com/trials/apricot-l-study-to-evaluate-efficacy-and-safety-of-apricoxib-with-erlotinib-in-patients-with-non-small-cell-lung-cancer-53885https://curecurrent.com/trials/phase-ii-study-of-e7389-halichondrin-b-analogue-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-who-progresse-53886https://curecurrent.com/trials/study-of-oral-topotecan-with-bevacizumab-for-recurrent-small-cell-lung-cancer-53887https://curecurrent.com/trials/venous-thromboembolism-and-haemostatic-disturbances-in-patients-with-upper-gastrointestinal-cancer-53888https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-recurrent-refractory-or-metastatic-solid-tumors-or-lymphomas-53889https://curecurrent.com/trials/safety-study-of-xl147-sar245408-in-combination-with-erlotinib-in-adults-with-solid-tumors-53890https://curecurrent.com/trials/a-phase-i-ii-study-of-first-line-vorinostat-with-pemetrexed-cisplatin-in-patients-with-malignant-pleural-mesothelioma-53891https://curecurrent.com/trials/autologous-cik-cells-infusion-for-the-treatment-of-lung-cancer-a-randomized-controlled-study-53892https://curecurrent.com/trials/dendritic-cells-in-lung-cancer-53893https://curecurrent.com/trials/11c-topotecan-pet-imaging-53894https://curecurrent.com/trials/phase-i-ii-trial-of-ptk787-and-pemetrexed-with-or-without-cisplatin-for-lung-cancer-53895https://curecurrent.com/trials/improving-clinical-pet-ct-image-quality-in-retrospectively-reconstructed-breath-hold-images-53896https://curecurrent.com/trials/vandetanib-and-bevacizumab-in-treating-patients-with-advanced-solid-tumors-or-lymphoma-53897https://curecurrent.com/trials/breathing-synchronized-pet-ct-scans-for-the-detection-of-malignant-lung-liver-lesions-and-assessment-of-tumor-glycolysis-53898https://curecurrent.com/trials/carboplatin-and-etoposide-with-or-without-thalidomide-in-treating-patients-with-limited-stage-or-extensive-stage-small-c-53899https://curecurrent.com/trials/inhaled-doxorubicin-in-treating-patients-with-advanced-solid-tumors-affecting-the-lungs-53900https://curecurrent.com/trials/safety-and-efficacy-of-talactoferrin-in-addition-to-standard-chemotherapy-in-patients-with-non-small-cell-lung-cancer-53901https://curecurrent.com/trials/systemic-intrapulmonary-and-pleural-inflammatory-reaction-in-patients-undergoing-thoracic-surgery-53902https://curecurrent.com/trials/everolimus-and-whole-brain-radiation-therapy-in-treating-patients-with-brain-metastasis-from-non-small-cell-lung-cancer-53903https://curecurrent.com/trials/phase-ii-study-alimta-and-gemzar-avastin-as-first-line-chemotherapy-for-elderly-patients-with-stage-iiib-iv-nsclc-53904https://curecurrent.com/trials/studying-genes-in-blood-and-lung-fluid-samples-from-patients-with-chronic-obstructive-pulmonary-disease-with-or-without-53905https://curecurrent.com/trials/acapha-in-preventing-lung-cancer-in-former-smokers-with-bronchial-intraepithelial-neoplasia-53906https://curecurrent.com/trials/green-tea-extract-in-preventing-cancer-in-former-and-current-heavy-smokers-with-abnormal-sputum-53907https://curecurrent.com/trials/green-tea-extract-in-treating-current-or-former-smokers-with-bronchial-dysplasia-53908https://curecurrent.com/trials/screening-methods-in-finding-lung-cancer-early-in-current-or-former-smokers-53909https://curecurrent.com/trials/vaccination-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-53910https://curecurrent.com/trials/irinotecan-and-gemcitabine-in-treating-patients-with-recurrent-or-progressive-stage-iii-or-stage-iv-non-small-cell-lung-53911https://curecurrent.com/trials/carboplatin-ixabepilone-and-cetuximab-in-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-previously-untre-53912https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer-53913https://curecurrent.com/trials/a-phase-ii-study-of-tx-regimen-as-first-line-treatment-for-asian-elderly-patients-with-advanced-adenocarcinoma-of-lung-53914https://curecurrent.com/trials/exhaled-breath-biomarkers-in-lung-cancer-53915https://curecurrent.com/trials/evaluation-of-chronic-pain-after-nerve-section-during-thoracotomy-53916https://curecurrent.com/trials/tarceva-italian-lung-optimization-trial-53917https://curecurrent.com/trials/pilot-study-of-18f-flt-pet-53918https://curecurrent.com/trials/phase-i-study-of-iv-dotap-cholesterol-fus1-in-non-small-cell-lung-cancer-53919https://curecurrent.com/trials/vitamin-e-in-preventing-the-side-effects-of-isotretinoin-in-former-and-current-smokers-who-are-receiving-isotretinoin-to-53920https://curecurrent.com/trials/stereotactic-body-radiation-therapy-sbrt-for-lung-tumors-53921https://curecurrent.com/trials/study-of-the-efficacy-of-an-investigational-drug-in-adult-patients-with-non-small-cell-lung-cancer-nsclc-53922https://curecurrent.com/trials/feasibility-study-comparison-of-performance-status-with-objective-physical-activity-monitors-53923https://curecurrent.com/trials/a-study-of-apatinib-in-patients-with-advanced-non-squamous-and-non-small-cell-lung-cancer-53924https://curecurrent.com/trials/3-screen-electronic-alert-53925https://curecurrent.com/trials/inno-206-in-patients-with-small-cell-lung-cancer-sclc-53926https://curecurrent.com/trials/phase-i-ii-for-patients-with-recurrent-or-refractory-non-small-cell-lung-cancer-nsclc-53927https://curecurrent.com/trials/paclitaxel-carboplatin-alone-or-with-m2es-for-non-small-cell-lung-cancer-53928https://curecurrent.com/trials/a-study-of-ogx-011-gemcitabine-platinum-based-regimen-in-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-53929https://curecurrent.com/trials/safety-study-of-xl765-sar245409-in-combination-with-erlotinib-in-adults-with-solid-tumors-53930https://curecurrent.com/trials/safety-study-of-mkc-1-combined-with-pemetrexed-to-treat-advanced-cancer-and-non-small-cell-lung-cancer-53931https://curecurrent.com/trials/study-in-nsclc-is-timely-analysis-of-egfr-mutation-status-feasible-in-region-antwerp-belgium-53932https://curecurrent.com/trials/imatinib-mesylate-and-docetaxel-in-non-small-cell-lung-cancer-nsclc-53933https://curecurrent.com/trials/tissue-collection-study-for-patients-with-non-small-cell-lung-cancer-with-resectable-disease-53934https://curecurrent.com/trials/accuracy-of-the-d-dimer-assay-for-the-exclusion-of-pulmonary-embolism-in-a-high-risk-oncologic-population-53935https://curecurrent.com/trials/validation-of-a-novel-thoracic-neoplasm-radiotherapy-image-guidance-technique-a-pilot-study-53936https://curecurrent.com/trials/cisplatin-etoposide-and-concurrent-radiotherapy-with-or-without-celecoxib-in-patients-with-unresectable-locally-advanced-53937https://curecurrent.com/trials/whole-body-magnetic-resonance-imaging-positron-emission-tomography-mri-pet-in-the-staging-of-non-small-cell-lung-cancer-53938https://curecurrent.com/trials/a-study-comparing-of-two-different-chemotherapy-regimens-in-patients-with-advanced-non-squamous-non-small-cell-lung-canc-53939https://curecurrent.com/trials/effects-of-different-i-e-ratio-on-intrapulmonary-shunt-fraction-and-oxygenation-during-one-lung-ventilation-in-the-later-53940https://curecurrent.com/trials/erlotinib-versus-vinorelbine-cisplatin-as-adjuvant-treatment-in-stage-iiia-nsclc-patients-with-egfr-mutations-53941https://curecurrent.com/trials/a-phase-ii-clinical-trial-of-docetaxel-oxaliplatin-combination-chemotherapy-in-patients-with-stage-iiib-iv-non-adenocarc-53942https://curecurrent.com/trials/screening-for-lung-cancer-in-current-or-past-smokers-with-chronic-obstructive-pulmonary-disease-53943https://curecurrent.com/trials/study-of-etoposide-cisplatin-and-radiotherapy-versus-paclitaxel-carboplatin-and-radiotherapy-to-treat-non-small-cell-lun-53944https://curecurrent.com/trials/ebus-tbna-for-diagnosis-of-mediastinal-lymphadenopathy-53945https://curecurrent.com/trials/interactive-voice-response-ivr-symptom-assessment-in-non-small-cell-lung-cancer-nsclc-patients-53946https://curecurrent.com/trials/endobronchial-ultrasound-guided-transbronchial-lung-biopsy-with-or-without-guide-sheath-in-lung-tumors-and-the-analysis-53947https://curecurrent.com/trials/wbrt-erlotinib-in-advanced-nsclc-and-brain-metastases-53948https://curecurrent.com/trials/zalutumumab-in-combination-with-chemo-radiation-in-a-certain-type-of-lung-cancer-53949https://curecurrent.com/trials/study-of-early-stage-lung-adenocarcinoma-for-early-detection-and-effective-treatment-strategy-53950https://curecurrent.com/trials/study-for-therapy-of-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-with-cisplatin-docetaxel-or-oxalipl-53951https://curecurrent.com/trials/positron-emission-tomography-pet-imaging-in-stage-iii-non-small-cell-lung-cancer-pet-start-trial-53952https://curecurrent.com/trials/detection-of-early-lung-cancer-by-serum-protein-expression-profiling-53953https://curecurrent.com/trials/measurement-of-pain-and-other-symptoms-of-non-small-cell-lung-cancer-nsclc-patients-following-thoracic-surgery-53954https://curecurrent.com/trials/genasense-oblimersen-sodium-fludarabine-and-rituximab-in-subjects-with-chronic-lymphocytic-leukemia-53955https://curecurrent.com/trials/induction-chemotherapy-followed-by-ccrt-according-to-egfr-mutation-status-in-nsclc-iii-53956https://curecurrent.com/trials/effects-of-selected-vegetable-and-herb-mix-sv-on-advanced-non-small-cell-lung-cancer-53957https://curecurrent.com/trials/velcade-and-eloxatin-for-patients-with-malignant-pleural-or-peritoneal-mesothelioma-53958https://curecurrent.com/trials/surveillance-study-of-viral-infections-following-lung-transplantation-53959https://curecurrent.com/trials/pulmonary-hypertension-in-lymphangioleiomyomatosis-53960https://curecurrent.com/trials/fdg-pet-to-investigate-sgn-15-and-docetaxel-in-patients-with-advanced-non-small-cell-lung-carcinoma-53961https://curecurrent.com/trials/safety-efficacy-study-of-immunoconjugate-with-docetaxel-in-non-small-cell-lung-carcinoma-53962https://curecurrent.com/trials/molecular-profiling-in-lung-cancer-patients-53963https://curecurrent.com/trials/efficacy-and-safety-study-of-osi-211-liposomal-lurtotecan-to-treat-recurrent-small-cell-lung-cancer-53964https://curecurrent.com/trials/phase-ii-study-of-taxotere-in-combination-with-exisulind-in-non-small-cell-lung-cancer-nsclc-patients-53965https://curecurrent.com/trials/a-phase-iii-study-of-the-efficacy-of-taxotere-aptosyn-versus-taxotere-placebo-in-non-small-cell-lung-cancer-patients-53966https://curecurrent.com/trials/chloroquinoxaline-sulfonamide-in-treating-patients-with-small-cell-lung-cancer-53967https://curecurrent.com/trials/external-validation-trial-of-aster-trial-53968https://curecurrent.com/trials/dose-escalation-study-of-arq-621-in-adult-patients-with-metastatic-solid-tumors-and-hematologic-malignancies-53969https://curecurrent.com/trials/a-clinical-trial-of-endobronchial-ultrasound-for-the-diagnosis-of-mediastinal-lymphadenopathy-remedy-53970https://curecurrent.com/trials/docetaxel-oxaliplatin-in-combination-with-bevacizumab-as-first-line-treatment-in-subjects-with-non-small-cell-lung-cance-53971https://curecurrent.com/trials/a-study-of-the-interaction-between-tumor-susceptibility-gene-glycine-n-methyltransferase-gnmt-and-lung-cancer-53972https://curecurrent.com/trials/study-of-xl281-in-adults-with-solid-tumors-53973https://curecurrent.com/trials/study-of-pemetrexed-versus-pemetrexed-plus-erlotinib-as-treatment-of-nonsquamous-non-small-cell-lung-cancer-nsclc-53974https://curecurrent.com/trials/observations-from-long-term-responders-in-the-gefitinib-iressa-expanded-access-program-eap-53975https://curecurrent.com/trials/zalutumumab-in-non-small-cell-lung-cancer-nsclc-patients-refractory-to-tyrosine-kinase-inhibitors-53976https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-non-small-cell-lung-cancer-nsclc-stages-iiib-iv-53977https://curecurrent.com/trials/neuropathic-in-the-acute-post-operative-phase-53978https://curecurrent.com/trials/pemetrexed-followed-by-docetaxel-or-in-reverse-sequence-53979https://curecurrent.com/trials/sensory-mapping-and-thermal-thresholds-after-thoracic-surgery-53980https://curecurrent.com/trials/multicentre-study-to-explore-the-correlation-between-smoking-pattern-and-clinical-efficacy-of-epidermal-growth-factor-re-53981https://curecurrent.com/trials/mistletoe-as-complementary-treatment-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-treated-with-carboplatin-53982https://curecurrent.com/trials/phase-1-study-of-osi-930-in-cancer-patients-53983https://curecurrent.com/trials/novottf-100l-in-combination-with-pemetrexed-alimta-for-advanced-non-small-cell-lung-cancer-53984https://curecurrent.com/trials/prospective-study-of-quality-of-life-in-non-small-cell-lung-cancer-nsclc-patients-treated-with-without-postoperative-rad-53985https://curecurrent.com/trials/concurrent-chemoradiotherapy-ccrt-with-paclitaxel-plus-cisplatin-in-la-non-small-cell-lung-cancer-nsclc-53986https://curecurrent.com/trials/a-study-of-cbt-1-and-paclitaxel-with-carboplatin-in-patients-with-advanced-inoperable-non-small-cell-lung-cancer-53987https://curecurrent.com/trials/a-prospective-study-of-variation-in-breath-holding-times-at-various-phases-of-respiration-during-the-course-of-radiother-53988https://curecurrent.com/trials/combination-chemotherapy-with-sildenafil-plus-carboplatin-and-paclitaxel-in-patients-with-advanced-non-small-cell-lung-c-53989https://curecurrent.com/trials/gemcitabine-and-carboplatin-for-elderly-patient-with-lung-cancer-53990https://curecurrent.com/trials/molecular-assessment-of-lymph-nodes-in-patients-with-resected-stage-i-to-iiia-non-small-cell-lung-cancer-53991https://curecurrent.com/trials/chronic-pain-following-thoracic-surgery-53992https://curecurrent.com/trials/tumor-metabolism-of-lung-cancer-in-patients-who-underwent-percutaneous-radiation-measured-with-f-18-fdg-pet-53993https://curecurrent.com/trials/phase-1-2-study-of-vascular-disrupting-agent-npi-2358-docetaxel-in-patients-with-advanced-non-small-cell-lung-cancer-53994https://curecurrent.com/trials/trial-of-pasireotidelar-and-topotecan-in-relapsed-or-refractory-small-cell-lung-cancer-53995https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-53996https://curecurrent.com/trials/dalteparin-in-preventing-blood-clots-in-patients-with-lung-cancer-53997https://curecurrent.com/trials/to-study-the-changes-in-protein-in-lung-cells-of-asian-patients-with-advanced-non-small-cell-lung-cancer-nsclc-53998https://curecurrent.com/trials/first-line-chemotherapy-with-or-without-neuromuscular-electrical-stimulation-in-treating-patients-with-non-small-cell-lu-53999https://curecurrent.com/trials/ct-based-versus-conventional-simulation-for-palliative-radiotherapy-of-non-small-cell-lung-cancer-54000